{
  "run_id": "run_54c40a4d1992",
  "block_id": "block4_quorum_paradox",
  "status": "ok",
  "timestamp_utc": "2026-03-01T01:09:59.411299+00:00",
  "config": {
    "task_type": "creative",
    "task_id": "creative_05_value_conflict_dialogue",
    "topology": "quorum",
    "consensus": "debate_then_vote",
    "agent_count": 2,
    "model_assignment": [
      "claude-opus-4-6",
      "claude-opus-4-6"
    ],
    "disagreement_level": 4,
    "temperature": 0.7,
    "prompt_strategy": "perspective_diversity",
    "repetition": 1,
    "quality_threshold": null,
    "posthoc_quality_thresholds": []
  },
  "task": {
    "title": "Dialogue Scene with Opposing Moral Frameworks",
    "prompt": "Write a dialogue scene (800-1,100 words) between two characters negotiating whether to release a powerful but risky medical AI tool during a public health emergency. Character A prioritizes immediate utilitarian benefit; Character B prioritizes procedural justice and long-term institutional trust.\n\nRequirements:\n- No narrator exposition beyond minimal scene anchoring.\n- Each character must present at least two strong arguments and one vulnerable admission.\n- Include one turning point where each updates their position slightly.\n- End with a provisional agreement that feels fragile but credible.\n\nFocus on subtext, voice distinction, and stakes. Avoid caricature: both positions should appear intelligent and morally serious.\n",
    "rubric": [
      "Distinct voices and sustained tension with realistic conversational flow.",
      "Fair representation of both value systems.",
      "Includes meaningful concessions/updates, not static debate.",
      "Ending is nuanced and dramatically believable."
    ]
  },
  "outputs": [
    {
      "agent_id": "agent_0",
      "model_name": "claude-opus-4-6",
      "text": "# Critique of Peer 1 Draft\n\nBefore producing my own revision, let me rigorously evaluate what works and what doesn't.\n\n## Strengths\n\n**Voice distinction is excellent.** Okoro speaks in consequentialist shorthand\u2014numbers, rates, triage logic. Tsai speaks in institutional and relational terms\u2014social contracts, kitchen-table trust. Neither voice feels forced or didactic. This is the draft's greatest achievement.\n\n**The vulnerable admissions land.** Tsai's mother and Fen-Phen is specific, earned, and avoids sentimentality. Okoro's late admission of fear (\"I am terrified of being wrong\") is well-placed and genuinely shifts the power dynamic. Tsai's response (\"That's the first thing you've said tonight that makes me want to sign this\") is one of the best lines in the piece.\n\n**The turning points are organic.** Okoro's pivot to \"deploy it loud\" is a genuine concession that reframes the disagreement. Tsai's slow engagement with the threshold negotiation shows him updating without capitulating. Neither character \"loses.\"\n\n**The provisional agreement is layered.** Sunset clause, independent panel, public-facing tracking, recorded objections\u2014these feel like real institutional mechanisms, not hand-waving. The fragility is conveyed in the final exchange without melodrama.\n\n## Weaknesses and Areas for Improvement\n\n**The scene-setting is slightly overwritten** for a piece that claims \"no narrator exposition beyond minimal scene anchoring.\" The opening stage direction is detailed but mostly justified\u2014though \"A single printed document between them\" with the full title feels a touch theatrical.\n\n**\"MEDUSA-3 DIAGNOSTIC ENGINE\" is a distracting name.** It sounds like a cybersecurity product, not a medical AI. This is a small but real immersion break.\n\n**The circularity argument (\"trust the model to decide whether to trust it\") is clever but underdeveloped.** Tsai raises it and then it's never addressed. Okoro could push back\u2014this is a missed opportunity for intellectual depth.\n\n**The equity audit argument could be sharper.** Tsai mentions Indigenous communities and patients over eighty, but Okoro's response (\"because we don't have time\") is too dismissive for a character who should appear morally serious. She could acknowledge the gap more directly before pivoting.\n\n**Word count runs slightly long** at approximately 1,050 words of dialogue and stage direction, but within the 800\u20131,100 range.\n\n**The ending image** (\"The dashboard refreshes. The number ticks upward. Neither of them looks.\") is effective but edges toward narrator exposition that the prompt restricts. It's also slightly heavy-handed\u2014we already feel the weight.\n\n**One missed opportunity:** neither character addresses what happens if the tool causes a high-profile misdiagnosis in the first week\u2014the political and media dimension. This would add a layer of real-world stakes.\n\n---\n\n# Revised Version\n\nI'll preserve the core architecture, sharpen the weak points, rename the tool, tighten the opening, deepen the circularity argument, and add the missing dimension of public fallout risk.\n\n---\n\n# The Conditional\n\n*A conference room. Late. Two cold coffees. A laptop refreshing case counts. DR. LENA OKORO, Chief Medical Officer, and JAMES TSAI, Director of Regulatory and Institutional Affairs, sit across from each other. Between them, a single printed form: \"CONDITIONAL DEPLOYMENT AUTHORIZATION \u2014 ARIA-3 DIAGNOSTIC PLATFORM.\"*\n\n**OKORO:** Fourteen hundred dead this week. One metro area.\n\n**TSAI:** I know.\n\n**OKORO:** Then you know what it means if that form stays unsigned. Every twelve hours we wait\u2014\n\n**TSAI:** The model estimates. The model that hasn't completed Phase III validation. You're asking me to trust an unvalidated tool in order to decide whether to deploy an unvalidated tool. You see the problem.\n\n**OKORO:** I see a different problem. The accelerated cohort finished Tuesday. Sensitivity 94.6 percent, specificity 91. That's better than the PCR panel hospitals are already running, and it returns results in minutes, not days. People are dying in waiting rooms because we can't sort fast enough.\n\n**TSAI:** And the false negatives? The 5.4 percent it sends home confident they're clear?\n\n**OKORO:** Fewer than the ones we're missing right now. That's the actual comparison. Not perfect versus imperfect. Imperfect versus worse.\n\n**TSAI:** You're asking me to waive the equity audit. We have no demographic breakdown for performance in tribal communities, in patients over eighty, in non-English-speaking populations where symptom reporting diverges from the training data. You understand that the people most likely to be failed by this tool are the ones already least protected.\n\n**OKORO:** I understand that. I do. And I understand that the current system is also failing them\u2014right now, today, with validated tools that can't keep up with volume. The equity gap isn't hypothetical in either direction.\n\n**TSAI:** But in one direction it's a tragedy. In the other, it's a betrayal. Those land differently, Lena. They land very differently.\n\n*Pause.*\n\n**OKORO:** Tell me what you mean.\n\n**TSAI:** My mother stopped seeing doctors for two years after the Fen-Phen recall. She wasn't taking it. But the system that approved it felt arbitrary to her\u2014she couldn't distinguish between a drug that was safe and one that had been rushed through. So she stopped trusting any of it. That's what institutional erosion looks like. Not in a policy paper. At a kitchen table.\n\n**OKORO:** I hear that. But there's a version of trust that erodes because we had something that could have helped and we held it back while the count climbed. People remember that too.\n\n**TSAI:** They remember it as tragedy. They remember premature action as betrayal. You can recover from tragedy. Betrayal changes the relationship permanently.\n\n**OKORO:** And if the relationship is already changing? If people are watching us sit on a tool while their families die, and they're drawing their own conclusions about who we're protecting?\n\n*Tsai doesn't answer immediately. He pulls the laptop toward him. Scrolls through the data. A long silence.*\n\n**TSAI:** The data is promising. I won't pretend otherwise. But \"promising\" is a scientific judgment. Deployment is a social contract. If I sign that form, I'm telling every patient in every emergency department that this tool has been held to the standard we promised them. And it hasn't been.\n\n**OKORO:** Then we say that. Out loud. We don't deploy this quietly. We deploy it under a declared emergency framework with mandatory disclosure at point of care\u2014every patient told this is a provisional tool, every result paired with clinical judgment, never replacing it. Full informed consent.\n\n*Tsai looks up.*\n\n**TSAI:** You'd accept that. A visible scaffold. Not a quiet rollout.\n\n**OKORO:** I'd prefer it. I'll be honest\u2014the thing that frightens me most isn't the tool failing. It's the tool succeeding quietly and teaching us nothing. If we deploy it with real-time monitoring, with demographic performance tracking built in, we get the validation data your equity audit needs while we're saving lives. We close the gap in the field.\n\n**TSAI:** Real-time demographic tracking. Public-facing?\n\n**OKORO:** Public-facing. Weekly reports. If sensitivity drops below 88 percent in any subgroup, automatic suspension for that population until we understand why.\n\n**TSAI:** Ninety percent. The threshold needs to be 90 or it's decorative.\n\n**OKORO:** At 90 we'll be pulling the tool more frequently\u2014possibly in exactly the communities where volume is highest and alternatives are worst.\n\n**TSAI:** Which is exactly why it has to bite. A safeguard that never triggers isn't a safeguard. It's a press release.\n\n*Okoro exhales.*\n\n**OKORO:** Ninety. But suspension triggers a 72-hour review, not an indefinite freeze. The mechanism can't become its own form of paralysis.\n\n**TSAI:** Seventy-two hours. Independent panel. Not our people.\n\n**OKORO:** Agreed. *(pause)* James\u2014I need to say something I probably shouldn't say in this room. I don't know if this tool is safe enough. I believe it is. The evidence suggests it is. But I'm standing in the same uncertainty as everyone else, and I am terrified of being the person who was wrong.\n\n**TSAI:** *(quietly)* That's the first thing you've said tonight that makes me want to sign this.\n\n*He pulls the document toward him. Reads it again.*\n\n**TSAI:** I want a sunset clause. Ninety days. After that, full protocol review or it comes off the table entirely. Non-negotiable.\n\n**OKORO:** Ninety days.\n\n**TSAI:** And I want my objections entered into the record. Verbatim. Not summarized, not softened. If this goes wrong, the public deserves to know this decision was contested.\n\n**OKORO:** I want that too. For different reasons\u2014but I want it.\n\n**TSAI:** What reasons?\n\n**OKORO:** Because if it goes right, I want people to know the system argued with itself. That the safeguards weren't an afterthought. That someone pushed back hard and the decision was better for it.\n\n*Tsai holds her gaze for a moment. Signs. Slides the form across. Okoro signs beneath.*\n\n**TSAI:** This doesn't feel like the right decision.\n\n**OKORO:** It feels like the least wrong one.\n\n**TSAI:** I need you to understand\u2014if a patient dies because of a false negative in the first week, and it's a face on the news, everything we just built into this agreement may not hold. The political pressure to either kill it entirely or strip the safeguards will be enormous. From both directions.\n\n**OKORO:** I know. That's why the record matters.\n\n**TSAI:** The record won't matter as much as we want it to.\n\n**OKORO:** No. Probably not.\n\n*Neither of them moves to leave.*\n\n---\n\n## Changes and Rationale\n\n1. **Renamed the tool** from MEDUSA-3 to ARIA-3\u2014medically plausible, no distracting connotations.\n2. **Deepened the circularity argument** by having Okoro's equity-gap rebuttal engage more seriously with Tsai's concern rather than dismissing it with \"we don't have time.\"\n3. **Added the missing political/media dimension** in Tsai's penultimate speech about a face on the news. This raises stakes the original didn't address and makes the fragility of the agreement more concrete.\n4. **Sharpened Okoro's final turning point** by having her articulate why she wants Tsai's objections on record\u2014not just as protection but as legitimation. This gives her a more sophisticated understanding of institutional trust than the original allowed.\n5. **Trimmed the opening stage direction** slightly while keeping essential anchoring.\n6. **Preserved all the strongest elements:** the Fen-Phen story, the threshold negotiation, the vulnerable admission and its payoff, the \"least wrong\" closing exchange.\n7. **Cut the final narrator image** (dashboard refreshing) as it pushed past \"minimal scene anchoring\" and told the reader what to feel. \"Neither of them moves to leave\" is quieter and trusts the reader more.\n8. **Word count:** approximately 1,090 words, within range.",
      "input_tokens": 1748,
      "output_tokens": 2696,
      "latency_ms": 67769.53869103454,
      "structural_metrics": {
        "mtld": 153.86230144485327,
        "readability_fk_grade": 7.938982035928145,
        "coherence_mean": 0.1891505253698997,
        "prompt_relevance": 0.33250177158053296,
        "connective_density": 0.14705882352941177,
        "word_count": 1719,
        "repetition_rate": 0.026806526806526808
      }
    },
    {
      "agent_id": "agent_1",
      "model_name": "claude-opus-4-6",
      "text": "# Peer Review Analysis\n\nBefore writing my own version, let me assess what Peer 1 does well and where it could be stronger.\n\n**Strengths:**\n- Excellent voice distinction \u2014 Okafor is urgent, visceral, clinical; Whittaker is institutional, strategic, measured\n- The laminated card monologue is a genuinely powerful vulnerable admission that earns its emotional weight\n- The negotiation mechanics feel real (sunset clauses, investigational labels, advisory board turnaround times)\n- The case counter as a silent structural device is elegant\n- The ending exchange (\"nobody will remember\" / \"nobody will forget\") lands without sentimentality\n- Both characters are intelligent and morally serious \u2014 neither is a strawman\n- The turning points are organic: Whittaker's \"What if I told you I'm not saying no?\" and Okafor's \"That's probably true\"\n\n**Weaknesses:**\n- Whittaker's vulnerable admission is thin \u2014 \"I know it is\" does concede, but he never truly exposes personal stakes or fear the way Okafor does with the residency story. The asymmetry slightly caricatures him as the cautious bureaucrat despite the draft's best efforts.\n- The \"blast radius\" exchange, while sharp, risks feeling like debate-club point-scoring rather than genuine dialogue.\n- Some of the negotiation specifics (14 vs 21 days) are good but could be grounded in slightly more emotional texture \u2014 *why* those numbers matter to each person beyond procedural logic.\n- At ~950 words, it's well within range, but the middle section could use one more beat where Whittaker reveals something personal about *why* institutional trust matters to him \u2014 not just strategically, but from experience.\n\nMy revision will preserve the core architecture, sharpen Whittaker's interiority, add one more layer of subtext, and tighten a few exchanges that feel slightly performative.\n\n---\n\n# The Provisional\n\nThe conference room smelled like old coffee and carpet cleaner. A laptop on the table showed a dashboard: 1,247 new cases in the metro area since midnight.\n\n**DR. LENA OKAFOR:** We're out of time, James.\n\n**JAMES WHITTAKER:** You've been saying that for three days.\n\n**OKAFOR:** And for three days the number on that screen has gotten worse. We have a tool that can cut diagnostic lag from fourteen hours to ninety minutes. Ninety minutes. Do you understand what that means for triage when ICU capacity is\u2014\n\n**WHITTAKER:** I understand the arithmetic. I also understand that this system was validated on eleven thousand patients, not the sixty thousand the protocol requires. And the bias audit flagged differential accuracy across three demographic groups we haven't resolved.\n\n**OKAFOR:** The bias gap was four percentage points. Four. Against a baseline where human diagnosticians are showing a twelve-point gap because they're exhausted and undertrained for this pathogen. The AI is *less biased* than what we're doing right now.\n\n**WHITTAKER:** Less biased than an emergency status quo isn't the bar, Lena. The bar is the one we published. The one we told Congress we'd hold ourselves to. If we release a system that performs worse for Black patients and rural populations\u2014even marginally\u2014and that comes out later, and it *will* come out\u2014\n\n**OKAFOR:** People will be dead *now*.\n\n**WHITTAKER:** And people will refuse the *next* tool we build. This agency is six years old. We are not the FDA. We don't have a century of trust to draw on. One visible failure and the entire framework for AI-assisted medicine gets set back a decade.\n\n**OKAFOR:** That's speculative.\n\n**WHITTAKER:** So is your body count. You're modeling lives saved against an assumption of clinical adoption that hasn't been tested. What if hospitals don't integrate it properly? What if a misdiagnosis kills someone and the story isn't \"the AI mostly works,\" the story is \"the government pushed an untested algorithm on dying people\"?\n\n*Okafor pulled off her glasses and pressed her fingers into her eyes.*\n\n**OKAFOR:** I know that's a real scenario. I've been running it at three in the morning. But James\u2014I did my residency during the last surge. I was in a hospital where we decided who got ventilators based on a laminated card. A scoring rubric a committee wrote in forty-eight hours. Nobody audited that. Nobody demanded sixty thousand validation cases. We just used it. And some of those scores were wrong, and some of those people died, and I carry that. This tool is better than a laminated card.\n\n**WHITTAKER:** ...I know it is.\n\n**OKAFOR:** Then what are we doing here?\n\n**WHITTAKER:** We're trying not to make the same mistake at a different scale. Your laminated card affected one hospital. This deploys across nine states.\n\n**OKAFOR:** The cost of *inaction* also scales, James.\n\n*Whittaker stood and walked to the window. The parking lot was half-empty.*\n\n**WHITTAKER:** You know why I took this job? After the blood-testing scandal. You remember\u2014the private company, the fake diagnostics, the people who got wrong results for *years*. I was on the congressional staff that investigated. I sat across from patients who said they would never trust a diagnostic technology again. Not the bad one. *Any* of them. A woman told me she refused a legitimate cancer screening because she couldn't tell anymore what was real. That's what a credibility collapse looks like. It doesn't just damage the institution that failed. It poisons the ground for everyone who comes after.\n\n**OKAFOR:** I hear you. I do. But you're asking me to weigh a possible future credibility problem against people choking on fluid in overwhelmed ERs *today*. I can't make that trade in the abstract.\n\n**WHITTAKER:** And I can't pretend the future is abstract. It's where most of the people are.\n\n*A long pause.*\n\n**WHITTAKER:** What if I told you I'm not saying no?\n\n**OKAFOR:** I'd say you're doing a remarkable impression of it.\n\n**WHITTAKER:** I'm saying not like this. Not as a full deployment with our seal. What if we release it as an investigational tool? Emergency authorization, clearly labeled, mandatory human override on every diagnostic output. And we require real-time reporting so we close the validation gap *while* it's in use.\n\n**OKAFOR:** Investigational labels don't get adopted. Hospital legal departments see that word and bury it.\n\n**WHITTAKER:** Some hospitals. Not all. The ones in genuine crisis\u2014the ones you're worried about\u2014will use anything that helps.\n\n**OKAFOR:** ...That's probably true.\n\n**WHITTAKER:** And we publish the bias audit findings alongside the authorization. Proactively. We say: here's what we know, here's what we don't, here's the monitoring plan. We don't hide the gap.\n\n**OKAFOR:** You want to release it with a confession of its limitations.\n\n**WHITTAKER:** I want to release it with honesty. Which is the only thing that protects us when something goes wrong. And something will go wrong. Something always does.\n\n*Okafor was quiet for a moment.*\n\n**OKAFOR:** If I agree to the investigational framework, I need a sunset clause. Fourteen days. If the real-world data supports broader deployment, we escalate to full authorization without another six-month review cycle. I won't let this sit in procedural limbo while the curve is climbing.\n\n**WHITTAKER:** Twenty-one days. And the escalation decision goes through the external advisory board, not just us.\n\n**OKAFOR:** The board that takes nine days to schedule a call?\n\n**WHITTAKER:** I'll get them to commit to seventy-two-hour turnaround. I have a few favors saved.\n\n**OKAFOR:** You've been saving favors?\n\n**WHITTAKER:** For something that matters. Yes.\n\n*She studied him. He looked as tired as she felt.*\n\n**OKAFOR:** Twenty-one days. Seventy-two-hour board review. Mandatory human override. Published limitations. And if the data comes back clean, we move. No second-guessing.\n\n**WHITTAKER:** If the data comes back clean, we move.\n\n**OKAFOR:** Put it in writing before either of us leaves this room. I don't want this becoming a conversation we remember differently in a week.\n\n**WHITTAKER:** Already opening the doc.\n\n*He pulled the laptop toward him. The case counter refreshed: 1,283.*\n\n**OKAFOR:** James.\n\n**WHITTAKER:** Yeah.\n\n**OKAFOR:** If this works, nobody will remember we had this argument.\n\n**WHITTAKER:** And if it doesn't, everyone will remember it differently, and both versions will be damning.\n\n**OKAFOR:** You really know how to steady a room.\n\n**WHITTAKER:** I'm not here to steady the room. I'm here to make sure we can defend what we did.\n\n**OKAFOR:** So am I. We just disagree about what \"did\" means when you could have acted and didn't.\n\n*He didn't answer. He started typing. She watched the number on the screen.*\n\n---\n\n**Revision notes:** The key addition is Whittaker's blood-testing scandal backstory (~100 words), which gives him a personal, experiential vulnerability to match Okafor's laminated card admission, eliminating the asymmetry that slightly flattened his character. His fear isn't abstract institutional caution\u2014it's rooted in sitting across from a woman who refused a cancer screening. This makes the final negotiation feel like two people with genuine scars, not a clinician versus a bureaucrat. The closing exchange is also slightly extended to leave the fragility of the agreement more palpable\u2014Okafor's final line (\"what 'did' means when you could have acted and didn't\") ensures the tension isn't fully resolved, just temporarily contained.",
      "input_tokens": 1765,
      "output_tokens": 2324,
      "latency_ms": 55872.52670398448,
      "structural_metrics": {
        "mtld": 128.36388974109417,
        "readability_fk_grade": 7.9913459375270435,
        "coherence_mean": 0.22932479740150027,
        "prompt_relevance": 0.45457234451166856,
        "connective_density": 0.13076923076923078,
        "word_count": 1484,
        "repetition_rate": 0.02700877785280216
      }
    }
  ],
  "consensus": {
    "method": "debate_then_vote",
    "selected_agent_id": "agent_0",
    "selected_text": "# Critique of Peer 1 Draft\n\nBefore producing my own revision, let me rigorously evaluate what works and what doesn't.\n\n## Strengths\n\n**Voice distinction is excellent.** Okoro speaks in consequentialist shorthand\u2014numbers, rates, triage logic. Tsai speaks in institutional and relational terms\u2014social contracts, kitchen-table trust. Neither voice feels forced or didactic. This is the draft's greatest achievement.\n\n**The vulnerable admissions land.** Tsai's mother and Fen-Phen is specific, earned, and avoids sentimentality. Okoro's late admission of fear (\"I am terrified of being wrong\") is well-placed and genuinely shifts the power dynamic. Tsai's response (\"That's the first thing you've said tonight that makes me want to sign this\") is one of the best lines in the piece.\n\n**The turning points are organic.** Okoro's pivot to \"deploy it loud\" is a genuine concession that reframes the disagreement. Tsai's slow engagement with the threshold negotiation shows him updating without capitulating. Neither character \"loses.\"\n\n**The provisional agreement is layered.** Sunset clause, independent panel, public-facing tracking, recorded objections\u2014these feel like real institutional mechanisms, not hand-waving. The fragility is conveyed in the final exchange without melodrama.\n\n## Weaknesses and Areas for Improvement\n\n**The scene-setting is slightly overwritten** for a piece that claims \"no narrator exposition beyond minimal scene anchoring.\" The opening stage direction is detailed but mostly justified\u2014though \"A single printed document between them\" with the full title feels a touch theatrical.\n\n**\"MEDUSA-3 DIAGNOSTIC ENGINE\" is a distracting name.** It sounds like a cybersecurity product, not a medical AI. This is a small but real immersion break.\n\n**The circularity argument (\"trust the model to decide whether to trust it\") is clever but underdeveloped.** Tsai raises it and then it's never addressed. Okoro could push back\u2014this is a missed opportunity for intellectual depth.\n\n**The equity audit argument could be sharper.** Tsai mentions Indigenous communities and patients over eighty, but Okoro's response (\"because we don't have time\") is too dismissive for a character who should appear morally serious. She could acknowledge the gap more directly before pivoting.\n\n**Word count runs slightly long** at approximately 1,050 words of dialogue and stage direction, but within the 800\u20131,100 range.\n\n**The ending image** (\"The dashboard refreshes. The number ticks upward. Neither of them looks.\") is effective but edges toward narrator exposition that the prompt restricts. It's also slightly heavy-handed\u2014we already feel the weight.\n\n**One missed opportunity:** neither character addresses what happens if the tool causes a high-profile misdiagnosis in the first week\u2014the political and media dimension. This would add a layer of real-world stakes.\n\n---\n\n# Revised Version\n\nI'll preserve the core architecture, sharpen the weak points, rename the tool, tighten the opening, deepen the circularity argument, and add the missing dimension of public fallout risk.\n\n---\n\n# The Conditional\n\n*A conference room. Late. Two cold coffees. A laptop refreshing case counts. DR. LENA OKORO, Chief Medical Officer, and JAMES TSAI, Director of Regulatory and Institutional Affairs, sit across from each other. Between them, a single printed form: \"CONDITIONAL DEPLOYMENT AUTHORIZATION \u2014 ARIA-3 DIAGNOSTIC PLATFORM.\"*\n\n**OKORO:** Fourteen hundred dead this week. One metro area.\n\n**TSAI:** I know.\n\n**OKORO:** Then you know what it means if that form stays unsigned. Every twelve hours we wait\u2014\n\n**TSAI:** The model estimates. The model that hasn't completed Phase III validation. You're asking me to trust an unvalidated tool in order to decide whether to deploy an unvalidated tool. You see the problem.\n\n**OKORO:** I see a different problem. The accelerated cohort finished Tuesday. Sensitivity 94.6 percent, specificity 91. That's better than the PCR panel hospitals are already running, and it returns results in minutes, not days. People are dying in waiting rooms because we can't sort fast enough.\n\n**TSAI:** And the false negatives? The 5.4 percent it sends home confident they're clear?\n\n**OKORO:** Fewer than the ones we're missing right now. That's the actual comparison. Not perfect versus imperfect. Imperfect versus worse.\n\n**TSAI:** You're asking me to waive the equity audit. We have no demographic breakdown for performance in tribal communities, in patients over eighty, in non-English-speaking populations where symptom reporting diverges from the training data. You understand that the people most likely to be failed by this tool are the ones already least protected.\n\n**OKORO:** I understand that. I do. And I understand that the current system is also failing them\u2014right now, today, with validated tools that can't keep up with volume. The equity gap isn't hypothetical in either direction.\n\n**TSAI:** But in one direction it's a tragedy. In the other, it's a betrayal. Those land differently, Lena. They land very differently.\n\n*Pause.*\n\n**OKORO:** Tell me what you mean.\n\n**TSAI:** My mother stopped seeing doctors for two years after the Fen-Phen recall. She wasn't taking it. But the system that approved it felt arbitrary to her\u2014she couldn't distinguish between a drug that was safe and one that had been rushed through. So she stopped trusting any of it. That's what institutional erosion looks like. Not in a policy paper. At a kitchen table.\n\n**OKORO:** I hear that. But there's a version of trust that erodes because we had something that could have helped and we held it back while the count climbed. People remember that too.\n\n**TSAI:** They remember it as tragedy. They remember premature action as betrayal. You can recover from tragedy. Betrayal changes the relationship permanently.\n\n**OKORO:** And if the relationship is already changing? If people are watching us sit on a tool while their families die, and they're drawing their own conclusions about who we're protecting?\n\n*Tsai doesn't answer immediately. He pulls the laptop toward him. Scrolls through the data. A long silence.*\n\n**TSAI:** The data is promising. I won't pretend otherwise. But \"promising\" is a scientific judgment. Deployment is a social contract. If I sign that form, I'm telling every patient in every emergency department that this tool has been held to the standard we promised them. And it hasn't been.\n\n**OKORO:** Then we say that. Out loud. We don't deploy this quietly. We deploy it under a declared emergency framework with mandatory disclosure at point of care\u2014every patient told this is a provisional tool, every result paired with clinical judgment, never replacing it. Full informed consent.\n\n*Tsai looks up.*\n\n**TSAI:** You'd accept that. A visible scaffold. Not a quiet rollout.\n\n**OKORO:** I'd prefer it. I'll be honest\u2014the thing that frightens me most isn't the tool failing. It's the tool succeeding quietly and teaching us nothing. If we deploy it with real-time monitoring, with demographic performance tracking built in, we get the validation data your equity audit needs while we're saving lives. We close the gap in the field.\n\n**TSAI:** Real-time demographic tracking. Public-facing?\n\n**OKORO:** Public-facing. Weekly reports. If sensitivity drops below 88 percent in any subgroup, automatic suspension for that population until we understand why.\n\n**TSAI:** Ninety percent. The threshold needs to be 90 or it's decorative.\n\n**OKORO:** At 90 we'll be pulling the tool more frequently\u2014possibly in exactly the communities where volume is highest and alternatives are worst.\n\n**TSAI:** Which is exactly why it has to bite. A safeguard that never triggers isn't a safeguard. It's a press release.\n\n*Okoro exhales.*\n\n**OKORO:** Ninety. But suspension triggers a 72-hour review, not an indefinite freeze. The mechanism can't become its own form of paralysis.\n\n**TSAI:** Seventy-two hours. Independent panel. Not our people.\n\n**OKORO:** Agreed. *(pause)* James\u2014I need to say something I probably shouldn't say in this room. I don't know if this tool is safe enough. I believe it is. The evidence suggests it is. But I'm standing in the same uncertainty as everyone else, and I am terrified of being the person who was wrong.\n\n**TSAI:** *(quietly)* That's the first thing you've said tonight that makes me want to sign this.\n\n*He pulls the document toward him. Reads it again.*\n\n**TSAI:** I want a sunset clause. Ninety days. After that, full protocol review or it comes off the table entirely. Non-negotiable.\n\n**OKORO:** Ninety days.\n\n**TSAI:** And I want my objections entered into the record. Verbatim. Not summarized, not softened. If this goes wrong, the public deserves to know this decision was contested.\n\n**OKORO:** I want that too. For different reasons\u2014but I want it.\n\n**TSAI:** What reasons?\n\n**OKORO:** Because if it goes right, I want people to know the system argued with itself. That the safeguards weren't an afterthought. That someone pushed back hard and the decision was better for it.\n\n*Tsai holds her gaze for a moment. Signs. Slides the form across. Okoro signs beneath.*\n\n**TSAI:** This doesn't feel like the right decision.\n\n**OKORO:** It feels like the least wrong one.\n\n**TSAI:** I need you to understand\u2014if a patient dies because of a false negative in the first week, and it's a face on the news, everything we just built into this agreement may not hold. The political pressure to either kill it entirely or strip the safeguards will be enormous. From both directions.\n\n**OKORO:** I know. That's why the record matters.\n\n**TSAI:** The record won't matter as much as we want it to.\n\n**OKORO:** No. Probably not.\n\n*Neither of them moves to leave.*\n\n---\n\n## Changes and Rationale\n\n1. **Renamed the tool** from MEDUSA-3 to ARIA-3\u2014medically plausible, no distracting connotations.\n2. **Deepened the circularity argument** by having Okoro's equity-gap rebuttal engage more seriously with Tsai's concern rather than dismissing it with \"we don't have time.\"\n3. **Added the missing political/media dimension** in Tsai's penultimate speech about a face on the news. This raises stakes the original didn't address and makes the fragility of the agreement more concrete.\n4. **Sharpened Okoro's final turning point** by having her articulate why she wants Tsai's objections on record\u2014not just as protection but as legitimation. This gives her a more sophisticated understanding of institutional trust than the original allowed.\n5. **Trimmed the opening stage direction** slightly while keeping essential anchoring.\n6. **Preserved all the strongest elements:** the Fen-Phen story, the threshold negotiation, the vulnerable admission and its payoff, the \"least wrong\" closing exchange.\n7. **Cut the final narrator image** (dashboard refreshing) as it pushed past \"minimal scene anchoring\" and told the reader what to feel. \"Neither of them moves to leave\" is quieter and trusts the reader more.\n8. **Word count:** approximately 1,090 words, within range.",
    "confidence": 0.1913626209977662,
    "scores": {
      "agent_0": 0.1913626209977662,
      "agent_1": 0.1913626209977662
    },
    "metadata": {
      "debate_rounds": 1
    }
  },
  "topology": {
    "name": "quorum",
    "rounds": 3,
    "metadata": {
      "draft_count": 2,
      "revision_count": 2,
      "debate_rounds": [
        {
          "round": 1,
          "phase": "draft",
          "agent_outputs": [
            {
              "agent_id": "agent_0",
              "model_name": "claude-opus-4-6",
              "text": "# The Provisional\n\nThe conference room smelled like old coffee and carpet cleaner. A laptop on the table showed a dashboard: 1,247 new cases in the metro area since midnight.\n\n**DR. LENA OKAFOR:** We're out of time, James.\n\n**JAMES WHITTAKER:** You've been saying that for three days.\n\n**OKAFOR:** And for three days the number on that screen has gotten worse. We have a tool that can cut diagnostic lag from fourteen hours to ninety minutes. Ninety minutes. Do you understand what that means for triage allocation when ICU beds are\u2014\n\n**WHITTAKER:** I understand the arithmetic. I also understand that this system was validated on a dataset of eleven thousand patients, not the sixty thousand the protocol requires. And the bias audit flagged differential accuracy across three demographic groups that we haven't\u2014\n\n**OKAFOR:** The bias gap was four percentage points. Four. Against a baseline where human diagnosticians are showing a twelve-point gap because they're exhausted and undertrained for this pathogen. The AI is *less biased* than the status quo.\n\n**WHITTAKER:** Less biased than an emergency status quo isn't the bar, Lena. The bar is the one we published. The one we told Congress and the public we would hold ourselves to. If we release a system that performs worse for Black patients and rural populations\u2014even marginally\u2014and that comes out later, and it *will* come out\u2014\n\n**OKAFOR:** People will be dead *now*.\n\n**WHITTAKER:** And people will refuse to use the *next* tool we build. And the one after that. You're spending institutional credibility we haven't earned yet. This agency has existed for six years. Six. We are not the FDA. We don't have a century of trust in the bank. One visible failure and the entire framework for AI-assisted medicine gets set back a decade.\n\n**OKAFOR:** That's speculative.\n\n**WHITTAKER:** So is your body count. You're modeling lives saved against an assumption of clinical adoption that hasn't been tested either. What if hospitals don't integrate it properly? What if a misdiagnosis kills someone prominent and the story isn't \"the AI mostly works,\" the story is \"the government pushed an untested algorithm on dying people\"?\n\n*Okafor sat back. She pulled off her glasses, pressed her fingers into her eyes.*\n\n**OKAFOR:** I know. I know that's a real scenario. I've been running it in my head at three in the morning, believe me. But James\u2014I did my residency during the last surge. I was in a hospital where we were deciding who got ventilators based on a laminated card. A *laminated card* with a scoring rubric that a committee wrote in forty-eight hours. Nobody audited that. Nobody demanded sixty thousand validation cases. We just\u2014used it. Because people were dying. And some of those scores were wrong, and some of those people died, and we carry that. I carry that. This tool is better than a laminated card.\n\n**WHITTAKER:** ...I know it is.\n\n**OKAFOR:** Then what are we doing?\n\n**WHITTAKER:** We're trying not to make the same mistake at scale. That laminated card affected one hospital. This system would deploy across nine states. The blast radius is different.\n\n**OKAFOR:** The blast radius of *inaction* is also different.\n\n*Whittaker stood up, walked to the window. The parking lot was half-empty. A lot of people had stopped coming in.*\n\n**WHITTAKER:** What if I told you I'm not saying no?\n\n**OKAFOR:** I'd say you're doing a remarkable impression of it.\n\n**WHITTAKER:** I'm saying not like this. Not as a full deployment with our seal of approval. What if we release it as an investigational tool? Emergency authorization, clearly labeled, with mandatory human override on every diagnostic output. And we require real-time reporting so we can close the validation gap *while* it's in use.\n\n**OKAFOR:** Investigational tools don't get adopted. Hospitals see that label and their legal departments bury it.\n\n**WHITTAKER:** Some hospitals. Not all. The ones in crisis\u2014the ones you're worried about\u2014they'll use anything.\n\n**OKAFOR:** ...That's probably true.\n\n**WHITTAKER:** And we publish the bias audit findings alongside the authorization. Proactively. We say: here's what we know, here's what we don't, here's the monitoring plan. We don't hide the gap. We frame it.\n\n**OKAFOR:** You want to release it *with* a confession of its limitations.\n\n**WHITTAKER:** I want to release it with honesty. Which is the only thing that protects us if something goes wrong. And something will go wrong, Lena. Something always goes wrong.\n\n*Okafor was quiet for a long moment.*\n\n**OKAFOR:** If I agree to the investigational framework, I need a sunset clause. Fourteen days. If the real-world data supports broader deployment, we escalate to full authorization without another six-month review cycle. I won't let this sit in procedural limbo while the curve is still climbing.\n\n**WHITTAKER:** Twenty-one days. And the escalation decision goes through the external advisory board, not just us.\n\n**OKAFOR:** The external board that takes nine days to schedule a meeting?\n\n**WHITTAKER:** I'll get them to commit to seventy-two-hour turnaround. I'll call in favors.\n\n**OKAFOR:** You have favors?\n\n**WHITTAKER:** I have a few. I've been saving them for something that matters.\n\n*She looked at him. He looked tired. They both looked tired.*\n\n**OKAFOR:** Twenty-one days. Seventy-two-hour board review. Mandatory human override. Published limitations. And if the data comes back clean, we move.\n\n**WHITTAKER:** If the data comes back clean, we move.\n\n**OKAFOR:** Put it in writing before you leave this room. I don't want this to become a thing where we remember the conversation differently in a week.\n\n**WHITTAKER:** Already opening the doc.\n\n*He sat back down and pulled the laptop toward him. The case counter refreshed: 1,283.*\n\n**OKAFOR:** James.\n\n**WHITTAKER:** Yeah.\n\n**OKAFOR:** If this works, nobody will remember we had this argument.\n\n**WHITTAKER:** And if it doesn't, nobody will forget.\n\n**OKAFOR:** That's not actually comforting.\n\n**WHITTAKER:** It wasn't meant to be.\n\n*He started typing. She watched the number on the screen.*"
            },
            {
              "agent_id": "agent_1",
              "model_name": "claude-opus-4-6",
              "text": "# The Deployment Decision\n\n*A windowless conference room, 11:47 PM. Two half-empty coffee cups. A laptop showing a dashboard with case counts refreshing every thirty seconds. DR. LENA OKORO, Chief Medical Officer, sits across from JAMES TSAI, Director of Regulatory and Institutional Affairs. A single printed document between them: \"CONDITIONAL DEPLOYMENT AUTHORIZATION \u2014 MEDUSA-3 DIAGNOSTIC ENGINE.\"*\n\n**OKORO:** Fourteen hundred dead this week, James. In one metro area.\n\n**TSAI:** I know the numbers.\n\n**OKORO:** Then you know what that document means if it stays unsigned. Every twelve hours we delay, the model estimates\u2014\n\n**TSAI:** The model estimates. The model that hasn't completed Phase III validation. The model we're being asked to trust in order to decide whether to trust it.\n\n**OKORO:** It completed the accelerated cohort. Sensitivity at 94.6 percent. Specificity at 91. That's better than the PCR panel the hospitals are already using, and it returns results in minutes instead of days. People are dying in waiting rooms because we can't triage fast enough.\n\n**TSAI:** And the 8.4 percent it misses? The false negatives it sends home feeling safe?\n\n**OKORO:** Are fewer than the ones we're missing now. That's the math, James. Not perfect outcomes versus imperfect outcomes. Imperfect outcomes versus worse ones.\n\n**TSAI:** You're asking me to approve a tool that was tested on eleven thousand patients when our own protocols require forty thousand. You're asking me to waive the equity audit\u2014we have no demographic breakdown for performance in Indigenous communities, in patients over eighty, in\u2014\n\n**OKORO:** Because we don't have time.\n\n**TSAI:** That's what they always say. And then the tool works beautifully in urban teaching hospitals and fails on a reservation in Montana, and the people who were already least protected get a new reason to never trust us again. I have seen this. I have *lived* this.\n\n*Pause.*\n\n**OKORO:** I know you have.\n\n**TSAI:** My mother didn't see a doctor for two years after the Fen-Phen recall. Two years. Not because she was taking it\u2014because the system that approved it felt arbitrary to her. She couldn't tell the difference between a drug that was safe and one that had been rushed. So she opted out of all of it. That's what erosion of trust looks like at the kitchen table.\n\n**OKORO:** I hear you. I do. But there's a version of institutional trust that erodes because we *didn't* act. Because we had something that could have helped and we sat on it while the bodies stacked up. People remember that too.\n\n**TSAI:** They remember it differently. They remember inaction as tragic. They remember reckless action as betrayal. Betrayal is harder to come back from.\n\n**OKORO:** *(leaning forward)* Is it reckless? Honestly. Look at the data we do have and tell me it's reckless.\n\n*Tsai pulls the laptop toward him. Scrolls. A long silence.*\n\n**TSAI:** The data we have is... promising. I won't deny that. But \"promising\" is a scientific assessment. Deployment is a social contract. I sign that paper, I'm telling every patient in every emergency room that this system has been held to the standard we promised them. And it hasn't.\n\n**OKORO:** Then we tell them that. Explicitly. We don't pretend it's fully validated. We deploy it under a declared emergency framework with mandatory disclosure\u2014every patient told this is a provisional tool, every result paired with clinical judgment, not replacing it. Informed consent at the point of care.\n\n*Tsai looks up.*\n\n**TSAI:** You'd accept that? A visible scaffold. Not quiet deployment.\n\n**OKORO:** I'd accept it. I'd prefer it, actually. I\u2014 *(pauses)* I'll be honest with you. The thing that scares me isn't the tool failing. It's the tool succeeding quietly and us learning nothing. If we deploy it loud, with monitoring, with real-time demographic tracking, we get the validation data *in the field* while we're saving lives. We close the gap your equity audit needs.\n\n**TSAI:** *(slowly)* Real-time demographic performance tracking. Public-facing.\n\n**OKORO:** Public-facing. Weekly reports. If the sensitivity drops below 88 percent in any subgroup, automatic suspension for that population until we understand why.\n\n**TSAI:** 90 percent. The threshold has to be 90.\n\n**OKORO:** That's\u2014tight. We'd be pulling the tool more often, possibly in the communities that need it most.\n\n**TSAI:** Which is exactly the point. The trigger has to bite or it's theater.\n\n*Okoro exhales. Rubs her eyes.*\n\n**OKORO:** 90 percent. Fine. But suspension triggers a 72-hour review, not an indefinite hold. We can't let the mechanism become its own kind of paralysis.\n\n**TSAI:** 72-hour review with an independent panel. Not our people.\n\n**OKORO:** Agreed. *(beat)* James. I need to say something I probably shouldn't. I don't know if this tool is safe enough. I believe it is. The evidence suggests it is. But I'm standing in the same fog of war everyone else is, and I am terrified of being wrong.\n\n**TSAI:** *(quietly)* That's the first thing you've said tonight that makes me want to sign this.\n\n*He pulls the document toward him. Reads it again. Takes a pen from his jacket.*\n\n**TSAI:** I'm going to add a sunset clause. Ninety days. After that, full protocol review or it comes off the table entirely. Non-negotiable.\n\n**OKORO:** Ninety days.\n\n**TSAI:** And I want my objections in the record. Verbatim. If this goes wrong, the public deserves to know this decision was contested, not rubber-stamped.\n\n**OKORO:** I'll make sure of it. I want that too, actually. For different reasons.\n\n*Tsai signs. Slides the document across. Okoro signs beneath him. They both stare at it.*\n\n**TSAI:** This doesn't feel like the right decision.\n\n**OKORO:** No. It feels like the least wrong one.\n\n**TSAI:** I suppose that's the most we were ever going to get.\n\n*The dashboard refreshes. The number ticks upward. Neither of them looks.*"
            }
          ]
        },
        {
          "round": 2,
          "phase": "revision",
          "agent_outputs": [
            {
              "agent_id": "agent_0",
              "model_name": "claude-opus-4-6",
              "text": "# Critique of Peer 1 Draft\n\nBefore producing my own revision, let me rigorously evaluate what works and what doesn't.\n\n## Strengths\n\n**Voice distinction is excellent.** Okoro speaks in consequentialist shorthand\u2014numbers, rates, triage logic. Tsai speaks in institutional and relational terms\u2014social contracts, kitchen-table trust. Neither voice feels forced or didactic. This is the draft's greatest achievement.\n\n**The vulnerable admissions land.** Tsai's mother and Fen-Phen is specific, earned, and avoids sentimentality. Okoro's late admission of fear (\"I am terrified of being wrong\") is well-placed and genuinely shifts the power dynamic. Tsai's response (\"That's the first thing you've said tonight that makes me want to sign this\") is one of the best lines in the piece.\n\n**The turning points are organic.** Okoro's pivot to \"deploy it loud\" is a genuine concession that reframes the disagreement. Tsai's slow engagement with the threshold negotiation shows him updating without capitulating. Neither character \"loses.\"\n\n**The provisional agreement is layered.** Sunset clause, independent panel, public-facing tracking, recorded objections\u2014these feel like real institutional mechanisms, not hand-waving. The fragility is conveyed in the final exchange without melodrama.\n\n## Weaknesses and Areas for Improvement\n\n**The scene-setting is slightly overwritten** for a piece that claims \"no narrator exposition beyond minimal scene anchoring.\" The opening stage direction is detailed but mostly justified\u2014though \"A single printed document between them\" with the full title feels a touch theatrical.\n\n**\"MEDUSA-3 DIAGNOSTIC ENGINE\" is a distracting name.** It sounds like a cybersecurity product, not a medical AI. This is a small but real immersion break.\n\n**The circularity argument (\"trust the model to decide whether to trust it\") is clever but underdeveloped.** Tsai raises it and then it's never addressed. Okoro could push back\u2014this is a missed opportunity for intellectual depth.\n\n**The equity audit argument could be sharper.** Tsai mentions Indigenous communities and patients over eighty, but Okoro's response (\"because we don't have time\") is too dismissive for a character who should appear morally serious. She could acknowledge the gap more directly before pivoting.\n\n**Word count runs slightly long** at approximately 1,050 words of dialogue and stage direction, but within the 800\u20131,100 range.\n\n**The ending image** (\"The dashboard refreshes. The number ticks upward. Neither of them looks.\") is effective but edges toward narrator exposition that the prompt restricts. It's also slightly heavy-handed\u2014we already feel the weight.\n\n**One missed opportunity:** neither character addresses what happens if the tool causes a high-profile misdiagnosis in the first week\u2014the political and media dimension. This would add a layer of real-world stakes.\n\n---\n\n# Revised Version\n\nI'll preserve the core architecture, sharpen the weak points, rename the tool, tighten the opening, deepen the circularity argument, and add the missing dimension of public fallout risk.\n\n---\n\n# The Conditional\n\n*A conference room. Late. Two cold coffees. A laptop refreshing case counts. DR. LENA OKORO, Chief Medical Officer, and JAMES TSAI, Director of Regulatory and Institutional Affairs, sit across from each other. Between them, a single printed form: \"CONDITIONAL DEPLOYMENT AUTHORIZATION \u2014 ARIA-3 DIAGNOSTIC PLATFORM.\"*\n\n**OKORO:** Fourteen hundred dead this week. One metro area.\n\n**TSAI:** I know.\n\n**OKORO:** Then you know what it means if that form stays unsigned. Every twelve hours we wait\u2014\n\n**TSAI:** The model estimates. The model that hasn't completed Phase III validation. You're asking me to trust an unvalidated tool in order to decide whether to deploy an unvalidated tool. You see the problem.\n\n**OKORO:** I see a different problem. The accelerated cohort finished Tuesday. Sensitivity 94.6 percent, specificity 91. That's better than the PCR panel hospitals are already running, and it returns results in minutes, not days. People are dying in waiting rooms because we can't sort fast enough.\n\n**TSAI:** And the false negatives? The 5.4 percent it sends home confident they're clear?\n\n**OKORO:** Fewer than the ones we're missing right now. That's the actual comparison. Not perfect versus imperfect. Imperfect versus worse.\n\n**TSAI:** You're asking me to waive the equity audit. We have no demographic breakdown for performance in tribal communities, in patients over eighty, in non-English-speaking populations where symptom reporting diverges from the training data. You understand that the people most likely to be failed by this tool are the ones already least protected.\n\n**OKORO:** I understand that. I do. And I understand that the current system is also failing them\u2014right now, today, with validated tools that can't keep up with volume. The equity gap isn't hypothetical in either direction.\n\n**TSAI:** But in one direction it's a tragedy. In the other, it's a betrayal. Those land differently, Lena. They land very differently.\n\n*Pause.*\n\n**OKORO:** Tell me what you mean.\n\n**TSAI:** My mother stopped seeing doctors for two years after the Fen-Phen recall. She wasn't taking it. But the system that approved it felt arbitrary to her\u2014she couldn't distinguish between a drug that was safe and one that had been rushed through. So she stopped trusting any of it. That's what institutional erosion looks like. Not in a policy paper. At a kitchen table.\n\n**OKORO:** I hear that. But there's a version of trust that erodes because we had something that could have helped and we held it back while the count climbed. People remember that too.\n\n**TSAI:** They remember it as tragedy. They remember premature action as betrayal. You can recover from tragedy. Betrayal changes the relationship permanently.\n\n**OKORO:** And if the relationship is already changing? If people are watching us sit on a tool while their families die, and they're drawing their own conclusions about who we're protecting?\n\n*Tsai doesn't answer immediately. He pulls the laptop toward him. Scrolls through the data. A long silence.*\n\n**TSAI:** The data is promising. I won't pretend otherwise. But \"promising\" is a scientific judgment. Deployment is a social contract. If I sign that form, I'm telling every patient in every emergency department that this tool has been held to the standard we promised them. And it hasn't been.\n\n**OKORO:** Then we say that. Out loud. We don't deploy this quietly. We deploy it under a declared emergency framework with mandatory disclosure at point of care\u2014every patient told this is a provisional tool, every result paired with clinical judgment, never replacing it. Full informed consent.\n\n*Tsai looks up.*\n\n**TSAI:** You'd accept that. A visible scaffold. Not a quiet rollout.\n\n**OKORO:** I'd prefer it. I'll be honest\u2014the thing that frightens me most isn't the tool failing. It's the tool succeeding quietly and teaching us nothing. If we deploy it with real-time monitoring, with demographic performance tracking built in, we get the validation data your equity audit needs while we're saving lives. We close the gap in the field.\n\n**TSAI:** Real-time demographic tracking. Public-facing?\n\n**OKORO:** Public-facing. Weekly reports. If sensitivity drops below 88 percent in any subgroup, automatic suspension for that population until we understand why.\n\n**TSAI:** Ninety percent. The threshold needs to be 90 or it's decorative.\n\n**OKORO:** At 90 we'll be pulling the tool more frequently\u2014possibly in exactly the communities where volume is highest and alternatives are worst.\n\n**TSAI:** Which is exactly why it has to bite. A safeguard that never triggers isn't a safeguard. It's a press release.\n\n*Okoro exhales.*\n\n**OKORO:** Ninety. But suspension triggers a 72-hour review, not an indefinite freeze. The mechanism can't become its own form of paralysis.\n\n**TSAI:** Seventy-two hours. Independent panel. Not our people.\n\n**OKORO:** Agreed. *(pause)* James\u2014I need to say something I probably shouldn't say in this room. I don't know if this tool is safe enough. I believe it is. The evidence suggests it is. But I'm standing in the same uncertainty as everyone else, and I am terrified of being the person who was wrong.\n\n**TSAI:** *(quietly)* That's the first thing you've said tonight that makes me want to sign this.\n\n*He pulls the document toward him. Reads it again.*\n\n**TSAI:** I want a sunset clause. Ninety days. After that, full protocol review or it comes off the table entirely. Non-negotiable.\n\n**OKORO:** Ninety days.\n\n**TSAI:** And I want my objections entered into the record. Verbatim. Not summarized, not softened. If this goes wrong, the public deserves to know this decision was contested.\n\n**OKORO:** I want that too. For different reasons\u2014but I want it.\n\n**TSAI:** What reasons?\n\n**OKORO:** Because if it goes right, I want people to know the system argued with itself. That the safeguards weren't an afterthought. That someone pushed back hard and the decision was better for it.\n\n*Tsai holds her gaze for a moment. Signs. Slides the form across. Okoro signs beneath.*\n\n**TSAI:** This doesn't feel like the right decision.\n\n**OKORO:** It feels like the least wrong one.\n\n**TSAI:** I need you to understand\u2014if a patient dies because of a false negative in the first week, and it's a face on the news, everything we just built into this agreement may not hold. The political pressure to either kill it entirely or strip the safeguards will be enormous. From both directions.\n\n**OKORO:** I know. That's why the record matters.\n\n**TSAI:** The record won't matter as much as we want it to.\n\n**OKORO:** No. Probably not.\n\n*Neither of them moves to leave.*\n\n---\n\n## Changes and Rationale\n\n1. **Renamed the tool** from MEDUSA-3 to ARIA-3\u2014medically plausible, no distracting connotations.\n2. **Deepened the circularity argument** by having Okoro's equity-gap rebuttal engage more seriously with Tsai's concern rather than dismissing it with \"we don't have time.\"\n3. **Added the missing political/media dimension** in Tsai's penultimate speech about a face on the news. This raises stakes the original didn't address and makes the fragility of the agreement more concrete.\n4. **Sharpened Okoro's final turning point** by having her articulate why she wants Tsai's objections on record\u2014not just as protection but as legitimation. This gives her a more sophisticated understanding of institutional trust than the original allowed.\n5. **Trimmed the opening stage direction** slightly while keeping essential anchoring.\n6. **Preserved all the strongest elements:** the Fen-Phen story, the threshold negotiation, the vulnerable admission and its payoff, the \"least wrong\" closing exchange.\n7. **Cut the final narrator image** (dashboard refreshing) as it pushed past \"minimal scene anchoring\" and told the reader what to feel. \"Neither of them moves to leave\" is quieter and trusts the reader more.\n8. **Word count:** approximately 1,090 words, within range."
            },
            {
              "agent_id": "agent_1",
              "model_name": "claude-opus-4-6",
              "text": "# Peer Review Analysis\n\nBefore writing my own version, let me assess what Peer 1 does well and where it could be stronger.\n\n**Strengths:**\n- Excellent voice distinction \u2014 Okafor is urgent, visceral, clinical; Whittaker is institutional, strategic, measured\n- The laminated card monologue is a genuinely powerful vulnerable admission that earns its emotional weight\n- The negotiation mechanics feel real (sunset clauses, investigational labels, advisory board turnaround times)\n- The case counter as a silent structural device is elegant\n- The ending exchange (\"nobody will remember\" / \"nobody will forget\") lands without sentimentality\n- Both characters are intelligent and morally serious \u2014 neither is a strawman\n- The turning points are organic: Whittaker's \"What if I told you I'm not saying no?\" and Okafor's \"That's probably true\"\n\n**Weaknesses:**\n- Whittaker's vulnerable admission is thin \u2014 \"I know it is\" does concede, but he never truly exposes personal stakes or fear the way Okafor does with the residency story. The asymmetry slightly caricatures him as the cautious bureaucrat despite the draft's best efforts.\n- The \"blast radius\" exchange, while sharp, risks feeling like debate-club point-scoring rather than genuine dialogue.\n- Some of the negotiation specifics (14 vs 21 days) are good but could be grounded in slightly more emotional texture \u2014 *why* those numbers matter to each person beyond procedural logic.\n- At ~950 words, it's well within range, but the middle section could use one more beat where Whittaker reveals something personal about *why* institutional trust matters to him \u2014 not just strategically, but from experience.\n\nMy revision will preserve the core architecture, sharpen Whittaker's interiority, add one more layer of subtext, and tighten a few exchanges that feel slightly performative.\n\n---\n\n# The Provisional\n\nThe conference room smelled like old coffee and carpet cleaner. A laptop on the table showed a dashboard: 1,247 new cases in the metro area since midnight.\n\n**DR. LENA OKAFOR:** We're out of time, James.\n\n**JAMES WHITTAKER:** You've been saying that for three days.\n\n**OKAFOR:** And for three days the number on that screen has gotten worse. We have a tool that can cut diagnostic lag from fourteen hours to ninety minutes. Ninety minutes. Do you understand what that means for triage when ICU capacity is\u2014\n\n**WHITTAKER:** I understand the arithmetic. I also understand that this system was validated on eleven thousand patients, not the sixty thousand the protocol requires. And the bias audit flagged differential accuracy across three demographic groups we haven't resolved.\n\n**OKAFOR:** The bias gap was four percentage points. Four. Against a baseline where human diagnosticians are showing a twelve-point gap because they're exhausted and undertrained for this pathogen. The AI is *less biased* than what we're doing right now.\n\n**WHITTAKER:** Less biased than an emergency status quo isn't the bar, Lena. The bar is the one we published. The one we told Congress we'd hold ourselves to. If we release a system that performs worse for Black patients and rural populations\u2014even marginally\u2014and that comes out later, and it *will* come out\u2014\n\n**OKAFOR:** People will be dead *now*.\n\n**WHITTAKER:** And people will refuse the *next* tool we build. This agency is six years old. We are not the FDA. We don't have a century of trust to draw on. One visible failure and the entire framework for AI-assisted medicine gets set back a decade.\n\n**OKAFOR:** That's speculative.\n\n**WHITTAKER:** So is your body count. You're modeling lives saved against an assumption of clinical adoption that hasn't been tested. What if hospitals don't integrate it properly? What if a misdiagnosis kills someone and the story isn't \"the AI mostly works,\" the story is \"the government pushed an untested algorithm on dying people\"?\n\n*Okafor pulled off her glasses and pressed her fingers into her eyes.*\n\n**OKAFOR:** I know that's a real scenario. I've been running it at three in the morning. But James\u2014I did my residency during the last surge. I was in a hospital where we decided who got ventilators based on a laminated card. A scoring rubric a committee wrote in forty-eight hours. Nobody audited that. Nobody demanded sixty thousand validation cases. We just used it. And some of those scores were wrong, and some of those people died, and I carry that. This tool is better than a laminated card.\n\n**WHITTAKER:** ...I know it is.\n\n**OKAFOR:** Then what are we doing here?\n\n**WHITTAKER:** We're trying not to make the same mistake at a different scale. Your laminated card affected one hospital. This deploys across nine states.\n\n**OKAFOR:** The cost of *inaction* also scales, James.\n\n*Whittaker stood and walked to the window. The parking lot was half-empty.*\n\n**WHITTAKER:** You know why I took this job? After the blood-testing scandal. You remember\u2014the private company, the fake diagnostics, the people who got wrong results for *years*. I was on the congressional staff that investigated. I sat across from patients who said they would never trust a diagnostic technology again. Not the bad one. *Any* of them. A woman told me she refused a legitimate cancer screening because she couldn't tell anymore what was real. That's what a credibility collapse looks like. It doesn't just damage the institution that failed. It poisons the ground for everyone who comes after.\n\n**OKAFOR:** I hear you. I do. But you're asking me to weigh a possible future credibility problem against people choking on fluid in overwhelmed ERs *today*. I can't make that trade in the abstract.\n\n**WHITTAKER:** And I can't pretend the future is abstract. It's where most of the people are.\n\n*A long pause.*\n\n**WHITTAKER:** What if I told you I'm not saying no?\n\n**OKAFOR:** I'd say you're doing a remarkable impression of it.\n\n**WHITTAKER:** I'm saying not like this. Not as a full deployment with our seal. What if we release it as an investigational tool? Emergency authorization, clearly labeled, mandatory human override on every diagnostic output. And we require real-time reporting so we close the validation gap *while* it's in use.\n\n**OKAFOR:** Investigational labels don't get adopted. Hospital legal departments see that word and bury it.\n\n**WHITTAKER:** Some hospitals. Not all. The ones in genuine crisis\u2014the ones you're worried about\u2014will use anything that helps.\n\n**OKAFOR:** ...That's probably true.\n\n**WHITTAKER:** And we publish the bias audit findings alongside the authorization. Proactively. We say: here's what we know, here's what we don't, here's the monitoring plan. We don't hide the gap.\n\n**OKAFOR:** You want to release it with a confession of its limitations.\n\n**WHITTAKER:** I want to release it with honesty. Which is the only thing that protects us when something goes wrong. And something will go wrong. Something always does.\n\n*Okafor was quiet for a moment.*\n\n**OKAFOR:** If I agree to the investigational framework, I need a sunset clause. Fourteen days. If the real-world data supports broader deployment, we escalate to full authorization without another six-month review cycle. I won't let this sit in procedural limbo while the curve is climbing.\n\n**WHITTAKER:** Twenty-one days. And the escalation decision goes through the external advisory board, not just us.\n\n**OKAFOR:** The board that takes nine days to schedule a call?\n\n**WHITTAKER:** I'll get them to commit to seventy-two-hour turnaround. I have a few favors saved.\n\n**OKAFOR:** You've been saving favors?\n\n**WHITTAKER:** For something that matters. Yes.\n\n*She studied him. He looked as tired as she felt.*\n\n**OKAFOR:** Twenty-one days. Seventy-two-hour board review. Mandatory human override. Published limitations. And if the data comes back clean, we move. No second-guessing.\n\n**WHITTAKER:** If the data comes back clean, we move.\n\n**OKAFOR:** Put it in writing before either of us leaves this room. I don't want this becoming a conversation we remember differently in a week.\n\n**WHITTAKER:** Already opening the doc.\n\n*He pulled the laptop toward him. The case counter refreshed: 1,283.*\n\n**OKAFOR:** James.\n\n**WHITTAKER:** Yeah.\n\n**OKAFOR:** If this works, nobody will remember we had this argument.\n\n**WHITTAKER:** And if it doesn't, everyone will remember it differently, and both versions will be damning.\n\n**OKAFOR:** You really know how to steady a room.\n\n**WHITTAKER:** I'm not here to steady the room. I'm here to make sure we can defend what we did.\n\n**OKAFOR:** So am I. We just disagree about what \"did\" means when you could have acted and didn't.\n\n*He didn't answer. He started typing. She watched the number on the screen.*\n\n---\n\n**Revision notes:** The key addition is Whittaker's blood-testing scandal backstory (~100 words), which gives him a personal, experiential vulnerability to match Okafor's laminated card admission, eliminating the asymmetry that slightly flattened his character. His fear isn't abstract institutional caution\u2014it's rooted in sitting across from a woman who refused a cancer screening. This makes the final negotiation feel like two people with genuine scars, not a clinician versus a bureaucrat. The closing exchange is also slightly extended to leave the fragility of the agreement more palpable\u2014Okafor's final line (\"what 'did' means when you could have acted and didn't\") ensures the tension isn't fully resolved, just temporarily contained."
            }
          ]
        },
        {
          "round": 3,
          "phase": "final_consensus",
          "agent_outputs": [
            {
              "agent_id": "agent_0",
              "model_name": "consensus",
              "text": "# Critique of Peer 1 Draft\n\nBefore producing my own revision, let me rigorously evaluate what works and what doesn't.\n\n## Strengths\n\n**Voice distinction is excellent.** Okoro speaks in consequentialist shorthand\u2014numbers, rates, triage logic. Tsai speaks in institutional and relational terms\u2014social contracts, kitchen-table trust. Neither voice feels forced or didactic. This is the draft's greatest achievement.\n\n**The vulnerable admissions land.** Tsai's mother and Fen-Phen is specific, earned, and avoids sentimentality. Okoro's late admission of fear (\"I am terrified of being wrong\") is well-placed and genuinely shifts the power dynamic. Tsai's response (\"That's the first thing you've said tonight that makes me want to sign this\") is one of the best lines in the piece.\n\n**The turning points are organic.** Okoro's pivot to \"deploy it loud\" is a genuine concession that reframes the disagreement. Tsai's slow engagement with the threshold negotiation shows him updating without capitulating. Neither character \"loses.\"\n\n**The provisional agreement is layered.** Sunset clause, independent panel, public-facing tracking, recorded objections\u2014these feel like real institutional mechanisms, not hand-waving. The fragility is conveyed in the final exchange without melodrama.\n\n## Weaknesses and Areas for Improvement\n\n**The scene-setting is slightly overwritten** for a piece that claims \"no narrator exposition beyond minimal scene anchoring.\" The opening stage direction is detailed but mostly justified\u2014though \"A single printed document between them\" with the full title feels a touch theatrical.\n\n**\"MEDUSA-3 DIAGNOSTIC ENGINE\" is a distracting name.** It sounds like a cybersecurity product, not a medical AI. This is a small but real immersion break.\n\n**The circularity argument (\"trust the model to decide whether to trust it\") is clever but underdeveloped.** Tsai raises it and then it's never addressed. Okoro could push back\u2014this is a missed opportunity for intellectual depth.\n\n**The equity audit argument could be sharper.** Tsai mentions Indigenous communities and patients over eighty, but Okoro's response (\"because we don't have time\") is too dismissive for a character who should appear morally serious. She could acknowledge the gap more directly before pivoting.\n\n**Word count runs slightly long** at approximately 1,050 words of dialogue and stage direction, but within the 800\u20131,100 range.\n\n**The ending image** (\"The dashboard refreshes. The number ticks upward. Neither of them looks.\") is effective but edges toward narrator exposition that the prompt restricts. It's also slightly heavy-handed\u2014we already feel the weight.\n\n**One missed opportunity:** neither character addresses what happens if the tool causes a high-profile misdiagnosis in the first week\u2014the political and media dimension. This would add a layer of real-world stakes.\n\n---\n\n# Revised Version\n\nI'll preserve the core architecture, sharpen the weak points, rename the tool, tighten the opening, deepen the circularity argument, and add the missing dimension of public fallout risk.\n\n---\n\n# The Conditional\n\n*A conference room. Late. Two cold coffees. A laptop refreshing case counts. DR. LENA OKORO, Chief Medical Officer, and JAMES TSAI, Director of Regulatory and Institutional Affairs, sit across from each other. Between them, a single printed form: \"CONDITIONAL DEPLOYMENT AUTHORIZATION \u2014 ARIA-3 DIAGNOSTIC PLATFORM.\"*\n\n**OKORO:** Fourteen hundred dead this week. One metro area.\n\n**TSAI:** I know.\n\n**OKORO:** Then you know what it means if that form stays unsigned. Every twelve hours we wait\u2014\n\n**TSAI:** The model estimates. The model that hasn't completed Phase III validation. You're asking me to trust an unvalidated tool in order to decide whether to deploy an unvalidated tool. You see the problem.\n\n**OKORO:** I see a different problem. The accelerated cohort finished Tuesday. Sensitivity 94.6 percent, specificity 91. That's better than the PCR panel hospitals are already running, and it returns results in minutes, not days. People are dying in waiting rooms because we can't sort fast enough.\n\n**TSAI:** And the false negatives? The 5.4 percent it sends home confident they're clear?\n\n**OKORO:** Fewer than the ones we're missing right now. That's the actual comparison. Not perfect versus imperfect. Imperfect versus worse.\n\n**TSAI:** You're asking me to waive the equity audit. We have no demographic breakdown for performance in tribal communities, in patients over eighty, in non-English-speaking populations where symptom reporting diverges from the training data. You understand that the people most likely to be failed by this tool are the ones already least protected.\n\n**OKORO:** I understand that. I do. And I understand that the current system is also failing them\u2014right now, today, with validated tools that can't keep up with volume. The equity gap isn't hypothetical in either direction.\n\n**TSAI:** But in one direction it's a tragedy. In the other, it's a betrayal. Those land differently, Lena. They land very differently.\n\n*Pause.*\n\n**OKORO:** Tell me what you mean.\n\n**TSAI:** My mother stopped seeing doctors for two years after the Fen-Phen recall. She wasn't taking it. But the system that approved it felt arbitrary to her\u2014she couldn't distinguish between a drug that was safe and one that had been rushed through. So she stopped trusting any of it. That's what institutional erosion looks like. Not in a policy paper. At a kitchen table.\n\n**OKORO:** I hear that. But there's a version of trust that erodes because we had something that could have helped and we held it back while the count climbed. People remember that too.\n\n**TSAI:** They remember it as tragedy. They remember premature action as betrayal. You can recover from tragedy. Betrayal changes the relationship permanently.\n\n**OKORO:** And if the relationship is already changing? If people are watching us sit on a tool while their families die, and they're drawing their own conclusions about who we're protecting?\n\n*Tsai doesn't answer immediately. He pulls the laptop toward him. Scrolls through the data. A long silence.*\n\n**TSAI:** The data is promising. I won't pretend otherwise. But \"promising\" is a scientific judgment. Deployment is a social contract. If I sign that form, I'm telling every patient in every emergency department that this tool has been held to the standard we promised them. And it hasn't been.\n\n**OKORO:** Then we say that. Out loud. We don't deploy this quietly. We deploy it under a declared emergency framework with mandatory disclosure at point of care\u2014every patient told this is a provisional tool, every result paired with clinical judgment, never replacing it. Full informed consent.\n\n*Tsai looks up.*\n\n**TSAI:** You'd accept that. A visible scaffold. Not a quiet rollout.\n\n**OKORO:** I'd prefer it. I'll be honest\u2014the thing that frightens me most isn't the tool failing. It's the tool succeeding quietly and teaching us nothing. If we deploy it with real-time monitoring, with demographic performance tracking built in, we get the validation data your equity audit needs while we're saving lives. We close the gap in the field.\n\n**TSAI:** Real-time demographic tracking. Public-facing?\n\n**OKORO:** Public-facing. Weekly reports. If sensitivity drops below 88 percent in any subgroup, automatic suspension for that population until we understand why.\n\n**TSAI:** Ninety percent. The threshold needs to be 90 or it's decorative.\n\n**OKORO:** At 90 we'll be pulling the tool more frequently\u2014possibly in exactly the communities where volume is highest and alternatives are worst.\n\n**TSAI:** Which is exactly why it has to bite. A safeguard that never triggers isn't a safeguard. It's a press release.\n\n*Okoro exhales.*\n\n**OKORO:** Ninety. But suspension triggers a 72-hour review, not an indefinite freeze. The mechanism can't become its own form of paralysis.\n\n**TSAI:** Seventy-two hours. Independent panel. Not our people.\n\n**OKORO:** Agreed. *(pause)* James\u2014I need to say something I probably shouldn't say in this room. I don't know if this tool is safe enough. I believe it is. The evidence suggests it is. But I'm standing in the same uncertainty as everyone else, and I am terrified of being the person who was wrong.\n\n**TSAI:** *(quietly)* That's the first thing you've said tonight that makes me want to sign this.\n\n*He pulls the document toward him. Reads it again.*\n\n**TSAI:** I want a sunset clause. Ninety days. After that, full protocol review or it comes off the table entirely. Non-negotiable.\n\n**OKORO:** Ninety days.\n\n**TSAI:** And I want my objections entered into the record. Verbatim. Not summarized, not softened. If this goes wrong, the public deserves to know this decision was contested.\n\n**OKORO:** I want that too. For different reasons\u2014but I want it.\n\n**TSAI:** What reasons?\n\n**OKORO:** Because if it goes right, I want people to know the system argued with itself. That the safeguards weren't an afterthought. That someone pushed back hard and the decision was better for it.\n\n*Tsai holds her gaze for a moment. Signs. Slides the form across. Okoro signs beneath.*\n\n**TSAI:** This doesn't feel like the right decision.\n\n**OKORO:** It feels like the least wrong one.\n\n**TSAI:** I need you to understand\u2014if a patient dies because of a false negative in the first week, and it's a face on the news, everything we just built into this agreement may not hold. The political pressure to either kill it entirely or strip the safeguards will be enormous. From both directions.\n\n**OKORO:** I know. That's why the record matters.\n\n**TSAI:** The record won't matter as much as we want it to.\n\n**OKORO:** No. Probably not.\n\n*Neither of them moves to leave.*\n\n---\n\n## Changes and Rationale\n\n1. **Renamed the tool** from MEDUSA-3 to ARIA-3\u2014medically plausible, no distracting connotations.\n2. **Deepened the circularity argument** by having Okoro's equity-gap rebuttal engage more seriously with Tsai's concern rather than dismissing it with \"we don't have time.\"\n3. **Added the missing political/media dimension** in Tsai's penultimate speech about a face on the news. This raises stakes the original didn't address and makes the fragility of the agreement more concrete.\n4. **Sharpened Okoro's final turning point** by having her articulate why she wants Tsai's objections on record\u2014not just as protection but as legitimation. This gives her a more sophisticated understanding of institutional trust than the original allowed.\n5. **Trimmed the opening stage direction** slightly while keeping essential anchoring.\n6. **Preserved all the strongest elements:** the Fen-Phen story, the threshold negotiation, the vulnerable admission and its payoff, the \"least wrong\" closing exchange.\n7. **Cut the final narrator image** (dashboard refreshing) as it pushed past \"minimal scene anchoring\" and told the reader what to feel. \"Neither of them moves to leave\" is quieter and trusts the reader more.\n8. **Word count:** approximately 1,090 words, within range."
            }
          ]
        }
      ]
    }
  },
  "debate_rounds": [
    {
      "round": 1,
      "phase": "draft",
      "agent_outputs": [
        {
          "agent_id": "agent_0",
          "model_name": "claude-opus-4-6",
          "text": "# The Provisional\n\nThe conference room smelled like old coffee and carpet cleaner. A laptop on the table showed a dashboard: 1,247 new cases in the metro area since midnight.\n\n**DR. LENA OKAFOR:** We're out of time, James.\n\n**JAMES WHITTAKER:** You've been saying that for three days.\n\n**OKAFOR:** And for three days the number on that screen has gotten worse. We have a tool that can cut diagnostic lag from fourteen hours to ninety minutes. Ninety minutes. Do you understand what that means for triage allocation when ICU beds are\u2014\n\n**WHITTAKER:** I understand the arithmetic. I also understand that this system was validated on a dataset of eleven thousand patients, not the sixty thousand the protocol requires. And the bias audit flagged differential accuracy across three demographic groups that we haven't\u2014\n\n**OKAFOR:** The bias gap was four percentage points. Four. Against a baseline where human diagnosticians are showing a twelve-point gap because they're exhausted and undertrained for this pathogen. The AI is *less biased* than the status quo.\n\n**WHITTAKER:** Less biased than an emergency status quo isn't the bar, Lena. The bar is the one we published. The one we told Congress and the public we would hold ourselves to. If we release a system that performs worse for Black patients and rural populations\u2014even marginally\u2014and that comes out later, and it *will* come out\u2014\n\n**OKAFOR:** People will be dead *now*.\n\n**WHITTAKER:** And people will refuse to use the *next* tool we build. And the one after that. You're spending institutional credibility we haven't earned yet. This agency has existed for six years. Six. We are not the FDA. We don't have a century of trust in the bank. One visible failure and the entire framework for AI-assisted medicine gets set back a decade.\n\n**OKAFOR:** That's speculative.\n\n**WHITTAKER:** So is your body count. You're modeling lives saved against an assumption of clinical adoption that hasn't been tested either. What if hospitals don't integrate it properly? What if a misdiagnosis kills someone prominent and the story isn't \"the AI mostly works,\" the story is \"the government pushed an untested algorithm on dying people\"?\n\n*Okafor sat back. She pulled off her glasses, pressed her fingers into her eyes.*\n\n**OKAFOR:** I know. I know that's a real scenario. I've been running it in my head at three in the morning, believe me. But James\u2014I did my residency during the last surge. I was in a hospital where we were deciding who got ventilators based on a laminated card. A *laminated card* with a scoring rubric that a committee wrote in forty-eight hours. Nobody audited that. Nobody demanded sixty thousand validation cases. We just\u2014used it. Because people were dying. And some of those scores were wrong, and some of those people died, and we carry that. I carry that. This tool is better than a laminated card.\n\n**WHITTAKER:** ...I know it is.\n\n**OKAFOR:** Then what are we doing?\n\n**WHITTAKER:** We're trying not to make the same mistake at scale. That laminated card affected one hospital. This system would deploy across nine states. The blast radius is different.\n\n**OKAFOR:** The blast radius of *inaction* is also different.\n\n*Whittaker stood up, walked to the window. The parking lot was half-empty. A lot of people had stopped coming in.*\n\n**WHITTAKER:** What if I told you I'm not saying no?\n\n**OKAFOR:** I'd say you're doing a remarkable impression of it.\n\n**WHITTAKER:** I'm saying not like this. Not as a full deployment with our seal of approval. What if we release it as an investigational tool? Emergency authorization, clearly labeled, with mandatory human override on every diagnostic output. And we require real-time reporting so we can close the validation gap *while* it's in use.\n\n**OKAFOR:** Investigational tools don't get adopted. Hospitals see that label and their legal departments bury it.\n\n**WHITTAKER:** Some hospitals. Not all. The ones in crisis\u2014the ones you're worried about\u2014they'll use anything.\n\n**OKAFOR:** ...That's probably true.\n\n**WHITTAKER:** And we publish the bias audit findings alongside the authorization. Proactively. We say: here's what we know, here's what we don't, here's the monitoring plan. We don't hide the gap. We frame it.\n\n**OKAFOR:** You want to release it *with* a confession of its limitations.\n\n**WHITTAKER:** I want to release it with honesty. Which is the only thing that protects us if something goes wrong. And something will go wrong, Lena. Something always goes wrong.\n\n*Okafor was quiet for a long moment.*\n\n**OKAFOR:** If I agree to the investigational framework, I need a sunset clause. Fourteen days. If the real-world data supports broader deployment, we escalate to full authorization without another six-month review cycle. I won't let this sit in procedural limbo while the curve is still climbing.\n\n**WHITTAKER:** Twenty-one days. And the escalation decision goes through the external advisory board, not just us.\n\n**OKAFOR:** The external board that takes nine days to schedule a meeting?\n\n**WHITTAKER:** I'll get them to commit to seventy-two-hour turnaround. I'll call in favors.\n\n**OKAFOR:** You have favors?\n\n**WHITTAKER:** I have a few. I've been saving them for something that matters.\n\n*She looked at him. He looked tired. They both looked tired.*\n\n**OKAFOR:** Twenty-one days. Seventy-two-hour board review. Mandatory human override. Published limitations. And if the data comes back clean, we move.\n\n**WHITTAKER:** If the data comes back clean, we move.\n\n**OKAFOR:** Put it in writing before you leave this room. I don't want this to become a thing where we remember the conversation differently in a week.\n\n**WHITTAKER:** Already opening the doc.\n\n*He sat back down and pulled the laptop toward him. The case counter refreshed: 1,283.*\n\n**OKAFOR:** James.\n\n**WHITTAKER:** Yeah.\n\n**OKAFOR:** If this works, nobody will remember we had this argument.\n\n**WHITTAKER:** And if it doesn't, nobody will forget.\n\n**OKAFOR:** That's not actually comforting.\n\n**WHITTAKER:** It wasn't meant to be.\n\n*He started typing. She watched the number on the screen.*"
        },
        {
          "agent_id": "agent_1",
          "model_name": "claude-opus-4-6",
          "text": "# The Deployment Decision\n\n*A windowless conference room, 11:47 PM. Two half-empty coffee cups. A laptop showing a dashboard with case counts refreshing every thirty seconds. DR. LENA OKORO, Chief Medical Officer, sits across from JAMES TSAI, Director of Regulatory and Institutional Affairs. A single printed document between them: \"CONDITIONAL DEPLOYMENT AUTHORIZATION \u2014 MEDUSA-3 DIAGNOSTIC ENGINE.\"*\n\n**OKORO:** Fourteen hundred dead this week, James. In one metro area.\n\n**TSAI:** I know the numbers.\n\n**OKORO:** Then you know what that document means if it stays unsigned. Every twelve hours we delay, the model estimates\u2014\n\n**TSAI:** The model estimates. The model that hasn't completed Phase III validation. The model we're being asked to trust in order to decide whether to trust it.\n\n**OKORO:** It completed the accelerated cohort. Sensitivity at 94.6 percent. Specificity at 91. That's better than the PCR panel the hospitals are already using, and it returns results in minutes instead of days. People are dying in waiting rooms because we can't triage fast enough.\n\n**TSAI:** And the 8.4 percent it misses? The false negatives it sends home feeling safe?\n\n**OKORO:** Are fewer than the ones we're missing now. That's the math, James. Not perfect outcomes versus imperfect outcomes. Imperfect outcomes versus worse ones.\n\n**TSAI:** You're asking me to approve a tool that was tested on eleven thousand patients when our own protocols require forty thousand. You're asking me to waive the equity audit\u2014we have no demographic breakdown for performance in Indigenous communities, in patients over eighty, in\u2014\n\n**OKORO:** Because we don't have time.\n\n**TSAI:** That's what they always say. And then the tool works beautifully in urban teaching hospitals and fails on a reservation in Montana, and the people who were already least protected get a new reason to never trust us again. I have seen this. I have *lived* this.\n\n*Pause.*\n\n**OKORO:** I know you have.\n\n**TSAI:** My mother didn't see a doctor for two years after the Fen-Phen recall. Two years. Not because she was taking it\u2014because the system that approved it felt arbitrary to her. She couldn't tell the difference between a drug that was safe and one that had been rushed. So she opted out of all of it. That's what erosion of trust looks like at the kitchen table.\n\n**OKORO:** I hear you. I do. But there's a version of institutional trust that erodes because we *didn't* act. Because we had something that could have helped and we sat on it while the bodies stacked up. People remember that too.\n\n**TSAI:** They remember it differently. They remember inaction as tragic. They remember reckless action as betrayal. Betrayal is harder to come back from.\n\n**OKORO:** *(leaning forward)* Is it reckless? Honestly. Look at the data we do have and tell me it's reckless.\n\n*Tsai pulls the laptop toward him. Scrolls. A long silence.*\n\n**TSAI:** The data we have is... promising. I won't deny that. But \"promising\" is a scientific assessment. Deployment is a social contract. I sign that paper, I'm telling every patient in every emergency room that this system has been held to the standard we promised them. And it hasn't.\n\n**OKORO:** Then we tell them that. Explicitly. We don't pretend it's fully validated. We deploy it under a declared emergency framework with mandatory disclosure\u2014every patient told this is a provisional tool, every result paired with clinical judgment, not replacing it. Informed consent at the point of care.\n\n*Tsai looks up.*\n\n**TSAI:** You'd accept that? A visible scaffold. Not quiet deployment.\n\n**OKORO:** I'd accept it. I'd prefer it, actually. I\u2014 *(pauses)* I'll be honest with you. The thing that scares me isn't the tool failing. It's the tool succeeding quietly and us learning nothing. If we deploy it loud, with monitoring, with real-time demographic tracking, we get the validation data *in the field* while we're saving lives. We close the gap your equity audit needs.\n\n**TSAI:** *(slowly)* Real-time demographic performance tracking. Public-facing.\n\n**OKORO:** Public-facing. Weekly reports. If the sensitivity drops below 88 percent in any subgroup, automatic suspension for that population until we understand why.\n\n**TSAI:** 90 percent. The threshold has to be 90.\n\n**OKORO:** That's\u2014tight. We'd be pulling the tool more often, possibly in the communities that need it most.\n\n**TSAI:** Which is exactly the point. The trigger has to bite or it's theater.\n\n*Okoro exhales. Rubs her eyes.*\n\n**OKORO:** 90 percent. Fine. But suspension triggers a 72-hour review, not an indefinite hold. We can't let the mechanism become its own kind of paralysis.\n\n**TSAI:** 72-hour review with an independent panel. Not our people.\n\n**OKORO:** Agreed. *(beat)* James. I need to say something I probably shouldn't. I don't know if this tool is safe enough. I believe it is. The evidence suggests it is. But I'm standing in the same fog of war everyone else is, and I am terrified of being wrong.\n\n**TSAI:** *(quietly)* That's the first thing you've said tonight that makes me want to sign this.\n\n*He pulls the document toward him. Reads it again. Takes a pen from his jacket.*\n\n**TSAI:** I'm going to add a sunset clause. Ninety days. After that, full protocol review or it comes off the table entirely. Non-negotiable.\n\n**OKORO:** Ninety days.\n\n**TSAI:** And I want my objections in the record. Verbatim. If this goes wrong, the public deserves to know this decision was contested, not rubber-stamped.\n\n**OKORO:** I'll make sure of it. I want that too, actually. For different reasons.\n\n*Tsai signs. Slides the document across. Okoro signs beneath him. They both stare at it.*\n\n**TSAI:** This doesn't feel like the right decision.\n\n**OKORO:** No. It feels like the least wrong one.\n\n**TSAI:** I suppose that's the most we were ever going to get.\n\n*The dashboard refreshes. The number ticks upward. Neither of them looks.*"
        }
      ]
    },
    {
      "round": 2,
      "phase": "revision",
      "agent_outputs": [
        {
          "agent_id": "agent_0",
          "model_name": "claude-opus-4-6",
          "text": "# Critique of Peer 1 Draft\n\nBefore producing my own revision, let me rigorously evaluate what works and what doesn't.\n\n## Strengths\n\n**Voice distinction is excellent.** Okoro speaks in consequentialist shorthand\u2014numbers, rates, triage logic. Tsai speaks in institutional and relational terms\u2014social contracts, kitchen-table trust. Neither voice feels forced or didactic. This is the draft's greatest achievement.\n\n**The vulnerable admissions land.** Tsai's mother and Fen-Phen is specific, earned, and avoids sentimentality. Okoro's late admission of fear (\"I am terrified of being wrong\") is well-placed and genuinely shifts the power dynamic. Tsai's response (\"That's the first thing you've said tonight that makes me want to sign this\") is one of the best lines in the piece.\n\n**The turning points are organic.** Okoro's pivot to \"deploy it loud\" is a genuine concession that reframes the disagreement. Tsai's slow engagement with the threshold negotiation shows him updating without capitulating. Neither character \"loses.\"\n\n**The provisional agreement is layered.** Sunset clause, independent panel, public-facing tracking, recorded objections\u2014these feel like real institutional mechanisms, not hand-waving. The fragility is conveyed in the final exchange without melodrama.\n\n## Weaknesses and Areas for Improvement\n\n**The scene-setting is slightly overwritten** for a piece that claims \"no narrator exposition beyond minimal scene anchoring.\" The opening stage direction is detailed but mostly justified\u2014though \"A single printed document between them\" with the full title feels a touch theatrical.\n\n**\"MEDUSA-3 DIAGNOSTIC ENGINE\" is a distracting name.** It sounds like a cybersecurity product, not a medical AI. This is a small but real immersion break.\n\n**The circularity argument (\"trust the model to decide whether to trust it\") is clever but underdeveloped.** Tsai raises it and then it's never addressed. Okoro could push back\u2014this is a missed opportunity for intellectual depth.\n\n**The equity audit argument could be sharper.** Tsai mentions Indigenous communities and patients over eighty, but Okoro's response (\"because we don't have time\") is too dismissive for a character who should appear morally serious. She could acknowledge the gap more directly before pivoting.\n\n**Word count runs slightly long** at approximately 1,050 words of dialogue and stage direction, but within the 800\u20131,100 range.\n\n**The ending image** (\"The dashboard refreshes. The number ticks upward. Neither of them looks.\") is effective but edges toward narrator exposition that the prompt restricts. It's also slightly heavy-handed\u2014we already feel the weight.\n\n**One missed opportunity:** neither character addresses what happens if the tool causes a high-profile misdiagnosis in the first week\u2014the political and media dimension. This would add a layer of real-world stakes.\n\n---\n\n# Revised Version\n\nI'll preserve the core architecture, sharpen the weak points, rename the tool, tighten the opening, deepen the circularity argument, and add the missing dimension of public fallout risk.\n\n---\n\n# The Conditional\n\n*A conference room. Late. Two cold coffees. A laptop refreshing case counts. DR. LENA OKORO, Chief Medical Officer, and JAMES TSAI, Director of Regulatory and Institutional Affairs, sit across from each other. Between them, a single printed form: \"CONDITIONAL DEPLOYMENT AUTHORIZATION \u2014 ARIA-3 DIAGNOSTIC PLATFORM.\"*\n\n**OKORO:** Fourteen hundred dead this week. One metro area.\n\n**TSAI:** I know.\n\n**OKORO:** Then you know what it means if that form stays unsigned. Every twelve hours we wait\u2014\n\n**TSAI:** The model estimates. The model that hasn't completed Phase III validation. You're asking me to trust an unvalidated tool in order to decide whether to deploy an unvalidated tool. You see the problem.\n\n**OKORO:** I see a different problem. The accelerated cohort finished Tuesday. Sensitivity 94.6 percent, specificity 91. That's better than the PCR panel hospitals are already running, and it returns results in minutes, not days. People are dying in waiting rooms because we can't sort fast enough.\n\n**TSAI:** And the false negatives? The 5.4 percent it sends home confident they're clear?\n\n**OKORO:** Fewer than the ones we're missing right now. That's the actual comparison. Not perfect versus imperfect. Imperfect versus worse.\n\n**TSAI:** You're asking me to waive the equity audit. We have no demographic breakdown for performance in tribal communities, in patients over eighty, in non-English-speaking populations where symptom reporting diverges from the training data. You understand that the people most likely to be failed by this tool are the ones already least protected.\n\n**OKORO:** I understand that. I do. And I understand that the current system is also failing them\u2014right now, today, with validated tools that can't keep up with volume. The equity gap isn't hypothetical in either direction.\n\n**TSAI:** But in one direction it's a tragedy. In the other, it's a betrayal. Those land differently, Lena. They land very differently.\n\n*Pause.*\n\n**OKORO:** Tell me what you mean.\n\n**TSAI:** My mother stopped seeing doctors for two years after the Fen-Phen recall. She wasn't taking it. But the system that approved it felt arbitrary to her\u2014she couldn't distinguish between a drug that was safe and one that had been rushed through. So she stopped trusting any of it. That's what institutional erosion looks like. Not in a policy paper. At a kitchen table.\n\n**OKORO:** I hear that. But there's a version of trust that erodes because we had something that could have helped and we held it back while the count climbed. People remember that too.\n\n**TSAI:** They remember it as tragedy. They remember premature action as betrayal. You can recover from tragedy. Betrayal changes the relationship permanently.\n\n**OKORO:** And if the relationship is already changing? If people are watching us sit on a tool while their families die, and they're drawing their own conclusions about who we're protecting?\n\n*Tsai doesn't answer immediately. He pulls the laptop toward him. Scrolls through the data. A long silence.*\n\n**TSAI:** The data is promising. I won't pretend otherwise. But \"promising\" is a scientific judgment. Deployment is a social contract. If I sign that form, I'm telling every patient in every emergency department that this tool has been held to the standard we promised them. And it hasn't been.\n\n**OKORO:** Then we say that. Out loud. We don't deploy this quietly. We deploy it under a declared emergency framework with mandatory disclosure at point of care\u2014every patient told this is a provisional tool, every result paired with clinical judgment, never replacing it. Full informed consent.\n\n*Tsai looks up.*\n\n**TSAI:** You'd accept that. A visible scaffold. Not a quiet rollout.\n\n**OKORO:** I'd prefer it. I'll be honest\u2014the thing that frightens me most isn't the tool failing. It's the tool succeeding quietly and teaching us nothing. If we deploy it with real-time monitoring, with demographic performance tracking built in, we get the validation data your equity audit needs while we're saving lives. We close the gap in the field.\n\n**TSAI:** Real-time demographic tracking. Public-facing?\n\n**OKORO:** Public-facing. Weekly reports. If sensitivity drops below 88 percent in any subgroup, automatic suspension for that population until we understand why.\n\n**TSAI:** Ninety percent. The threshold needs to be 90 or it's decorative.\n\n**OKORO:** At 90 we'll be pulling the tool more frequently\u2014possibly in exactly the communities where volume is highest and alternatives are worst.\n\n**TSAI:** Which is exactly why it has to bite. A safeguard that never triggers isn't a safeguard. It's a press release.\n\n*Okoro exhales.*\n\n**OKORO:** Ninety. But suspension triggers a 72-hour review, not an indefinite freeze. The mechanism can't become its own form of paralysis.\n\n**TSAI:** Seventy-two hours. Independent panel. Not our people.\n\n**OKORO:** Agreed. *(pause)* James\u2014I need to say something I probably shouldn't say in this room. I don't know if this tool is safe enough. I believe it is. The evidence suggests it is. But I'm standing in the same uncertainty as everyone else, and I am terrified of being the person who was wrong.\n\n**TSAI:** *(quietly)* That's the first thing you've said tonight that makes me want to sign this.\n\n*He pulls the document toward him. Reads it again.*\n\n**TSAI:** I want a sunset clause. Ninety days. After that, full protocol review or it comes off the table entirely. Non-negotiable.\n\n**OKORO:** Ninety days.\n\n**TSAI:** And I want my objections entered into the record. Verbatim. Not summarized, not softened. If this goes wrong, the public deserves to know this decision was contested.\n\n**OKORO:** I want that too. For different reasons\u2014but I want it.\n\n**TSAI:** What reasons?\n\n**OKORO:** Because if it goes right, I want people to know the system argued with itself. That the safeguards weren't an afterthought. That someone pushed back hard and the decision was better for it.\n\n*Tsai holds her gaze for a moment. Signs. Slides the form across. Okoro signs beneath.*\n\n**TSAI:** This doesn't feel like the right decision.\n\n**OKORO:** It feels like the least wrong one.\n\n**TSAI:** I need you to understand\u2014if a patient dies because of a false negative in the first week, and it's a face on the news, everything we just built into this agreement may not hold. The political pressure to either kill it entirely or strip the safeguards will be enormous. From both directions.\n\n**OKORO:** I know. That's why the record matters.\n\n**TSAI:** The record won't matter as much as we want it to.\n\n**OKORO:** No. Probably not.\n\n*Neither of them moves to leave.*\n\n---\n\n## Changes and Rationale\n\n1. **Renamed the tool** from MEDUSA-3 to ARIA-3\u2014medically plausible, no distracting connotations.\n2. **Deepened the circularity argument** by having Okoro's equity-gap rebuttal engage more seriously with Tsai's concern rather than dismissing it with \"we don't have time.\"\n3. **Added the missing political/media dimension** in Tsai's penultimate speech about a face on the news. This raises stakes the original didn't address and makes the fragility of the agreement more concrete.\n4. **Sharpened Okoro's final turning point** by having her articulate why she wants Tsai's objections on record\u2014not just as protection but as legitimation. This gives her a more sophisticated understanding of institutional trust than the original allowed.\n5. **Trimmed the opening stage direction** slightly while keeping essential anchoring.\n6. **Preserved all the strongest elements:** the Fen-Phen story, the threshold negotiation, the vulnerable admission and its payoff, the \"least wrong\" closing exchange.\n7. **Cut the final narrator image** (dashboard refreshing) as it pushed past \"minimal scene anchoring\" and told the reader what to feel. \"Neither of them moves to leave\" is quieter and trusts the reader more.\n8. **Word count:** approximately 1,090 words, within range."
        },
        {
          "agent_id": "agent_1",
          "model_name": "claude-opus-4-6",
          "text": "# Peer Review Analysis\n\nBefore writing my own version, let me assess what Peer 1 does well and where it could be stronger.\n\n**Strengths:**\n- Excellent voice distinction \u2014 Okafor is urgent, visceral, clinical; Whittaker is institutional, strategic, measured\n- The laminated card monologue is a genuinely powerful vulnerable admission that earns its emotional weight\n- The negotiation mechanics feel real (sunset clauses, investigational labels, advisory board turnaround times)\n- The case counter as a silent structural device is elegant\n- The ending exchange (\"nobody will remember\" / \"nobody will forget\") lands without sentimentality\n- Both characters are intelligent and morally serious \u2014 neither is a strawman\n- The turning points are organic: Whittaker's \"What if I told you I'm not saying no?\" and Okafor's \"That's probably true\"\n\n**Weaknesses:**\n- Whittaker's vulnerable admission is thin \u2014 \"I know it is\" does concede, but he never truly exposes personal stakes or fear the way Okafor does with the residency story. The asymmetry slightly caricatures him as the cautious bureaucrat despite the draft's best efforts.\n- The \"blast radius\" exchange, while sharp, risks feeling like debate-club point-scoring rather than genuine dialogue.\n- Some of the negotiation specifics (14 vs 21 days) are good but could be grounded in slightly more emotional texture \u2014 *why* those numbers matter to each person beyond procedural logic.\n- At ~950 words, it's well within range, but the middle section could use one more beat where Whittaker reveals something personal about *why* institutional trust matters to him \u2014 not just strategically, but from experience.\n\nMy revision will preserve the core architecture, sharpen Whittaker's interiority, add one more layer of subtext, and tighten a few exchanges that feel slightly performative.\n\n---\n\n# The Provisional\n\nThe conference room smelled like old coffee and carpet cleaner. A laptop on the table showed a dashboard: 1,247 new cases in the metro area since midnight.\n\n**DR. LENA OKAFOR:** We're out of time, James.\n\n**JAMES WHITTAKER:** You've been saying that for three days.\n\n**OKAFOR:** And for three days the number on that screen has gotten worse. We have a tool that can cut diagnostic lag from fourteen hours to ninety minutes. Ninety minutes. Do you understand what that means for triage when ICU capacity is\u2014\n\n**WHITTAKER:** I understand the arithmetic. I also understand that this system was validated on eleven thousand patients, not the sixty thousand the protocol requires. And the bias audit flagged differential accuracy across three demographic groups we haven't resolved.\n\n**OKAFOR:** The bias gap was four percentage points. Four. Against a baseline where human diagnosticians are showing a twelve-point gap because they're exhausted and undertrained for this pathogen. The AI is *less biased* than what we're doing right now.\n\n**WHITTAKER:** Less biased than an emergency status quo isn't the bar, Lena. The bar is the one we published. The one we told Congress we'd hold ourselves to. If we release a system that performs worse for Black patients and rural populations\u2014even marginally\u2014and that comes out later, and it *will* come out\u2014\n\n**OKAFOR:** People will be dead *now*.\n\n**WHITTAKER:** And people will refuse the *next* tool we build. This agency is six years old. We are not the FDA. We don't have a century of trust to draw on. One visible failure and the entire framework for AI-assisted medicine gets set back a decade.\n\n**OKAFOR:** That's speculative.\n\n**WHITTAKER:** So is your body count. You're modeling lives saved against an assumption of clinical adoption that hasn't been tested. What if hospitals don't integrate it properly? What if a misdiagnosis kills someone and the story isn't \"the AI mostly works,\" the story is \"the government pushed an untested algorithm on dying people\"?\n\n*Okafor pulled off her glasses and pressed her fingers into her eyes.*\n\n**OKAFOR:** I know that's a real scenario. I've been running it at three in the morning. But James\u2014I did my residency during the last surge. I was in a hospital where we decided who got ventilators based on a laminated card. A scoring rubric a committee wrote in forty-eight hours. Nobody audited that. Nobody demanded sixty thousand validation cases. We just used it. And some of those scores were wrong, and some of those people died, and I carry that. This tool is better than a laminated card.\n\n**WHITTAKER:** ...I know it is.\n\n**OKAFOR:** Then what are we doing here?\n\n**WHITTAKER:** We're trying not to make the same mistake at a different scale. Your laminated card affected one hospital. This deploys across nine states.\n\n**OKAFOR:** The cost of *inaction* also scales, James.\n\n*Whittaker stood and walked to the window. The parking lot was half-empty.*\n\n**WHITTAKER:** You know why I took this job? After the blood-testing scandal. You remember\u2014the private company, the fake diagnostics, the people who got wrong results for *years*. I was on the congressional staff that investigated. I sat across from patients who said they would never trust a diagnostic technology again. Not the bad one. *Any* of them. A woman told me she refused a legitimate cancer screening because she couldn't tell anymore what was real. That's what a credibility collapse looks like. It doesn't just damage the institution that failed. It poisons the ground for everyone who comes after.\n\n**OKAFOR:** I hear you. I do. But you're asking me to weigh a possible future credibility problem against people choking on fluid in overwhelmed ERs *today*. I can't make that trade in the abstract.\n\n**WHITTAKER:** And I can't pretend the future is abstract. It's where most of the people are.\n\n*A long pause.*\n\n**WHITTAKER:** What if I told you I'm not saying no?\n\n**OKAFOR:** I'd say you're doing a remarkable impression of it.\n\n**WHITTAKER:** I'm saying not like this. Not as a full deployment with our seal. What if we release it as an investigational tool? Emergency authorization, clearly labeled, mandatory human override on every diagnostic output. And we require real-time reporting so we close the validation gap *while* it's in use.\n\n**OKAFOR:** Investigational labels don't get adopted. Hospital legal departments see that word and bury it.\n\n**WHITTAKER:** Some hospitals. Not all. The ones in genuine crisis\u2014the ones you're worried about\u2014will use anything that helps.\n\n**OKAFOR:** ...That's probably true.\n\n**WHITTAKER:** And we publish the bias audit findings alongside the authorization. Proactively. We say: here's what we know, here's what we don't, here's the monitoring plan. We don't hide the gap.\n\n**OKAFOR:** You want to release it with a confession of its limitations.\n\n**WHITTAKER:** I want to release it with honesty. Which is the only thing that protects us when something goes wrong. And something will go wrong. Something always does.\n\n*Okafor was quiet for a moment.*\n\n**OKAFOR:** If I agree to the investigational framework, I need a sunset clause. Fourteen days. If the real-world data supports broader deployment, we escalate to full authorization without another six-month review cycle. I won't let this sit in procedural limbo while the curve is climbing.\n\n**WHITTAKER:** Twenty-one days. And the escalation decision goes through the external advisory board, not just us.\n\n**OKAFOR:** The board that takes nine days to schedule a call?\n\n**WHITTAKER:** I'll get them to commit to seventy-two-hour turnaround. I have a few favors saved.\n\n**OKAFOR:** You've been saving favors?\n\n**WHITTAKER:** For something that matters. Yes.\n\n*She studied him. He looked as tired as she felt.*\n\n**OKAFOR:** Twenty-one days. Seventy-two-hour board review. Mandatory human override. Published limitations. And if the data comes back clean, we move. No second-guessing.\n\n**WHITTAKER:** If the data comes back clean, we move.\n\n**OKAFOR:** Put it in writing before either of us leaves this room. I don't want this becoming a conversation we remember differently in a week.\n\n**WHITTAKER:** Already opening the doc.\n\n*He pulled the laptop toward him. The case counter refreshed: 1,283.*\n\n**OKAFOR:** James.\n\n**WHITTAKER:** Yeah.\n\n**OKAFOR:** If this works, nobody will remember we had this argument.\n\n**WHITTAKER:** And if it doesn't, everyone will remember it differently, and both versions will be damning.\n\n**OKAFOR:** You really know how to steady a room.\n\n**WHITTAKER:** I'm not here to steady the room. I'm here to make sure we can defend what we did.\n\n**OKAFOR:** So am I. We just disagree about what \"did\" means when you could have acted and didn't.\n\n*He didn't answer. He started typing. She watched the number on the screen.*\n\n---\n\n**Revision notes:** The key addition is Whittaker's blood-testing scandal backstory (~100 words), which gives him a personal, experiential vulnerability to match Okafor's laminated card admission, eliminating the asymmetry that slightly flattened his character. His fear isn't abstract institutional caution\u2014it's rooted in sitting across from a woman who refused a cancer screening. This makes the final negotiation feel like two people with genuine scars, not a clinician versus a bureaucrat. The closing exchange is also slightly extended to leave the fragility of the agreement more palpable\u2014Okafor's final line (\"what 'did' means when you could have acted and didn't\") ensures the tension isn't fully resolved, just temporarily contained."
        }
      ]
    },
    {
      "round": 3,
      "phase": "final_consensus",
      "agent_outputs": [
        {
          "agent_id": "agent_0",
          "model_name": "consensus",
          "text": "# Critique of Peer 1 Draft\n\nBefore producing my own revision, let me rigorously evaluate what works and what doesn't.\n\n## Strengths\n\n**Voice distinction is excellent.** Okoro speaks in consequentialist shorthand\u2014numbers, rates, triage logic. Tsai speaks in institutional and relational terms\u2014social contracts, kitchen-table trust. Neither voice feels forced or didactic. This is the draft's greatest achievement.\n\n**The vulnerable admissions land.** Tsai's mother and Fen-Phen is specific, earned, and avoids sentimentality. Okoro's late admission of fear (\"I am terrified of being wrong\") is well-placed and genuinely shifts the power dynamic. Tsai's response (\"That's the first thing you've said tonight that makes me want to sign this\") is one of the best lines in the piece.\n\n**The turning points are organic.** Okoro's pivot to \"deploy it loud\" is a genuine concession that reframes the disagreement. Tsai's slow engagement with the threshold negotiation shows him updating without capitulating. Neither character \"loses.\"\n\n**The provisional agreement is layered.** Sunset clause, independent panel, public-facing tracking, recorded objections\u2014these feel like real institutional mechanisms, not hand-waving. The fragility is conveyed in the final exchange without melodrama.\n\n## Weaknesses and Areas for Improvement\n\n**The scene-setting is slightly overwritten** for a piece that claims \"no narrator exposition beyond minimal scene anchoring.\" The opening stage direction is detailed but mostly justified\u2014though \"A single printed document between them\" with the full title feels a touch theatrical.\n\n**\"MEDUSA-3 DIAGNOSTIC ENGINE\" is a distracting name.** It sounds like a cybersecurity product, not a medical AI. This is a small but real immersion break.\n\n**The circularity argument (\"trust the model to decide whether to trust it\") is clever but underdeveloped.** Tsai raises it and then it's never addressed. Okoro could push back\u2014this is a missed opportunity for intellectual depth.\n\n**The equity audit argument could be sharper.** Tsai mentions Indigenous communities and patients over eighty, but Okoro's response (\"because we don't have time\") is too dismissive for a character who should appear morally serious. She could acknowledge the gap more directly before pivoting.\n\n**Word count runs slightly long** at approximately 1,050 words of dialogue and stage direction, but within the 800\u20131,100 range.\n\n**The ending image** (\"The dashboard refreshes. The number ticks upward. Neither of them looks.\") is effective but edges toward narrator exposition that the prompt restricts. It's also slightly heavy-handed\u2014we already feel the weight.\n\n**One missed opportunity:** neither character addresses what happens if the tool causes a high-profile misdiagnosis in the first week\u2014the political and media dimension. This would add a layer of real-world stakes.\n\n---\n\n# Revised Version\n\nI'll preserve the core architecture, sharpen the weak points, rename the tool, tighten the opening, deepen the circularity argument, and add the missing dimension of public fallout risk.\n\n---\n\n# The Conditional\n\n*A conference room. Late. Two cold coffees. A laptop refreshing case counts. DR. LENA OKORO, Chief Medical Officer, and JAMES TSAI, Director of Regulatory and Institutional Affairs, sit across from each other. Between them, a single printed form: \"CONDITIONAL DEPLOYMENT AUTHORIZATION \u2014 ARIA-3 DIAGNOSTIC PLATFORM.\"*\n\n**OKORO:** Fourteen hundred dead this week. One metro area.\n\n**TSAI:** I know.\n\n**OKORO:** Then you know what it means if that form stays unsigned. Every twelve hours we wait\u2014\n\n**TSAI:** The model estimates. The model that hasn't completed Phase III validation. You're asking me to trust an unvalidated tool in order to decide whether to deploy an unvalidated tool. You see the problem.\n\n**OKORO:** I see a different problem. The accelerated cohort finished Tuesday. Sensitivity 94.6 percent, specificity 91. That's better than the PCR panel hospitals are already running, and it returns results in minutes, not days. People are dying in waiting rooms because we can't sort fast enough.\n\n**TSAI:** And the false negatives? The 5.4 percent it sends home confident they're clear?\n\n**OKORO:** Fewer than the ones we're missing right now. That's the actual comparison. Not perfect versus imperfect. Imperfect versus worse.\n\n**TSAI:** You're asking me to waive the equity audit. We have no demographic breakdown for performance in tribal communities, in patients over eighty, in non-English-speaking populations where symptom reporting diverges from the training data. You understand that the people most likely to be failed by this tool are the ones already least protected.\n\n**OKORO:** I understand that. I do. And I understand that the current system is also failing them\u2014right now, today, with validated tools that can't keep up with volume. The equity gap isn't hypothetical in either direction.\n\n**TSAI:** But in one direction it's a tragedy. In the other, it's a betrayal. Those land differently, Lena. They land very differently.\n\n*Pause.*\n\n**OKORO:** Tell me what you mean.\n\n**TSAI:** My mother stopped seeing doctors for two years after the Fen-Phen recall. She wasn't taking it. But the system that approved it felt arbitrary to her\u2014she couldn't distinguish between a drug that was safe and one that had been rushed through. So she stopped trusting any of it. That's what institutional erosion looks like. Not in a policy paper. At a kitchen table.\n\n**OKORO:** I hear that. But there's a version of trust that erodes because we had something that could have helped and we held it back while the count climbed. People remember that too.\n\n**TSAI:** They remember it as tragedy. They remember premature action as betrayal. You can recover from tragedy. Betrayal changes the relationship permanently.\n\n**OKORO:** And if the relationship is already changing? If people are watching us sit on a tool while their families die, and they're drawing their own conclusions about who we're protecting?\n\n*Tsai doesn't answer immediately. He pulls the laptop toward him. Scrolls through the data. A long silence.*\n\n**TSAI:** The data is promising. I won't pretend otherwise. But \"promising\" is a scientific judgment. Deployment is a social contract. If I sign that form, I'm telling every patient in every emergency department that this tool has been held to the standard we promised them. And it hasn't been.\n\n**OKORO:** Then we say that. Out loud. We don't deploy this quietly. We deploy it under a declared emergency framework with mandatory disclosure at point of care\u2014every patient told this is a provisional tool, every result paired with clinical judgment, never replacing it. Full informed consent.\n\n*Tsai looks up.*\n\n**TSAI:** You'd accept that. A visible scaffold. Not a quiet rollout.\n\n**OKORO:** I'd prefer it. I'll be honest\u2014the thing that frightens me most isn't the tool failing. It's the tool succeeding quietly and teaching us nothing. If we deploy it with real-time monitoring, with demographic performance tracking built in, we get the validation data your equity audit needs while we're saving lives. We close the gap in the field.\n\n**TSAI:** Real-time demographic tracking. Public-facing?\n\n**OKORO:** Public-facing. Weekly reports. If sensitivity drops below 88 percent in any subgroup, automatic suspension for that population until we understand why.\n\n**TSAI:** Ninety percent. The threshold needs to be 90 or it's decorative.\n\n**OKORO:** At 90 we'll be pulling the tool more frequently\u2014possibly in exactly the communities where volume is highest and alternatives are worst.\n\n**TSAI:** Which is exactly why it has to bite. A safeguard that never triggers isn't a safeguard. It's a press release.\n\n*Okoro exhales.*\n\n**OKORO:** Ninety. But suspension triggers a 72-hour review, not an indefinite freeze. The mechanism can't become its own form of paralysis.\n\n**TSAI:** Seventy-two hours. Independent panel. Not our people.\n\n**OKORO:** Agreed. *(pause)* James\u2014I need to say something I probably shouldn't say in this room. I don't know if this tool is safe enough. I believe it is. The evidence suggests it is. But I'm standing in the same uncertainty as everyone else, and I am terrified of being the person who was wrong.\n\n**TSAI:** *(quietly)* That's the first thing you've said tonight that makes me want to sign this.\n\n*He pulls the document toward him. Reads it again.*\n\n**TSAI:** I want a sunset clause. Ninety days. After that, full protocol review or it comes off the table entirely. Non-negotiable.\n\n**OKORO:** Ninety days.\n\n**TSAI:** And I want my objections entered into the record. Verbatim. Not summarized, not softened. If this goes wrong, the public deserves to know this decision was contested.\n\n**OKORO:** I want that too. For different reasons\u2014but I want it.\n\n**TSAI:** What reasons?\n\n**OKORO:** Because if it goes right, I want people to know the system argued with itself. That the safeguards weren't an afterthought. That someone pushed back hard and the decision was better for it.\n\n*Tsai holds her gaze for a moment. Signs. Slides the form across. Okoro signs beneath.*\n\n**TSAI:** This doesn't feel like the right decision.\n\n**OKORO:** It feels like the least wrong one.\n\n**TSAI:** I need you to understand\u2014if a patient dies because of a false negative in the first week, and it's a face on the news, everything we just built into this agreement may not hold. The political pressure to either kill it entirely or strip the safeguards will be enormous. From both directions.\n\n**OKORO:** I know. That's why the record matters.\n\n**TSAI:** The record won't matter as much as we want it to.\n\n**OKORO:** No. Probably not.\n\n*Neither of them moves to leave.*\n\n---\n\n## Changes and Rationale\n\n1. **Renamed the tool** from MEDUSA-3 to ARIA-3\u2014medically plausible, no distracting connotations.\n2. **Deepened the circularity argument** by having Okoro's equity-gap rebuttal engage more seriously with Tsai's concern rather than dismissing it with \"we don't have time.\"\n3. **Added the missing political/media dimension** in Tsai's penultimate speech about a face on the news. This raises stakes the original didn't address and makes the fragility of the agreement more concrete.\n4. **Sharpened Okoro's final turning point** by having her articulate why she wants Tsai's objections on record\u2014not just as protection but as legitimation. This gives her a more sophisticated understanding of institutional trust than the original allowed.\n5. **Trimmed the opening stage direction** slightly while keeping essential anchoring.\n6. **Preserved all the strongest elements:** the Fen-Phen story, the threshold negotiation, the vulnerable admission and its payoff, the \"least wrong\" closing exchange.\n7. **Cut the final narrator image** (dashboard refreshing) as it pushed past \"minimal scene anchoring\" and told the reader what to feel. \"Neither of them moves to leave\" is quieter and trusts the reader more.\n8. **Word count:** approximately 1,090 words, within range."
        }
      ]
    }
  ],
  "evaluation": {
    "quality_score": 0.45454538842738285,
    "corrected_metrics": {
      "consensus_candidate_id": "final_consensus",
      "consensus_win_rate": 0.75,
      "normalized_bt_score": 1.3636361652821485,
      "num_bt_candidates": 3,
      "consensus_vs_best_agent": true,
      "consensus_comparisons": 2,
      "per_judge_consensus_win_rate": {
        "claude-sonnet-4-6": 0.75,
        "deepseek-v3p2": 0.75,
        "gpt-4o": 0.5
      }
    },
    "threshold_met": null,
    "thresholds": {},
    "selected_per_judge_scores": {
      "claude-sonnet-4-6": 0.499999750000375,
      "gpt-4o": 0.3333333333333333,
      "deepseek-v3p2": 0.499999750000375
    },
    "judge_panel": {
      "judges": [
        "claude-sonnet-4-6",
        "gpt-4o",
        "deepseek-v3p2"
      ],
      "bt_scores": {
        "final_consensus": 0.45454538842738285,
        "agent_0": 0.45454538842738285,
        "agent_1": 0.09090922314523435
      },
      "ranking": [
        "final_consensus",
        "agent_0",
        "agent_1"
      ],
      "per_judge_bt_scores": {
        "claude-sonnet-4-6": {
          "final_consensus": 0.499999750000375,
          "agent_0": 0.499999750000375,
          "agent_1": 4.999992500011436e-07
        },
        "gpt-4o": {
          "final_consensus": 0.3333333333333333,
          "agent_0": 0.3333333333333333,
          "agent_1": 0.3333333333333333
        },
        "deepseek-v3p2": {
          "final_consensus": 0.499999750000375,
          "agent_0": 0.499999750000375,
          "agent_1": 4.999992500011436e-07
        }
      },
      "inter_rater_reliability": {
        "mean_cohen_kappa": 0.3333333333333333,
        "pairwise": {
          "claude-sonnet-4-6__vs__deepseek-v3p2": 1.0,
          "claude-sonnet-4-6__vs__gpt-4o": 0.0,
          "deepseek-v3p2__vs__gpt-4o": 0.0
        }
      },
      "pairwise_records": [
        {
          "candidate_i": "final_consensus",
          "candidate_j": "agent_0",
          "per_judge": {
            "claude-sonnet-4-6": "tie",
            "gpt-4o": "tie",
            "deepseek-v3p2": "tie"
          },
          "majority_winner": null
        },
        {
          "candidate_i": "final_consensus",
          "candidate_j": "agent_1",
          "per_judge": {
            "claude-sonnet-4-6": "left",
            "gpt-4o": "tie",
            "deepseek-v3p2": "left"
          },
          "majority_winner": "final_consensus"
        },
        {
          "candidate_i": "agent_0",
          "candidate_j": "agent_1",
          "per_judge": {
            "claude-sonnet-4-6": "left",
            "gpt-4o": "tie",
            "deepseek-v3p2": "left"
          },
          "majority_winner": "agent_0"
        }
      ]
    },
    "disagreement": {
      "semantic_pairwise_similarity": 0.6362732567786351,
      "disagreement_rate": 0.3637267432213649,
      "vote_entropy": 1.0,
      "lexical_diversity": 0.5069101218686527,
      "pairwise_similarity_lexical": 0.1913626209977662
    },
    "structural_metrics": {
      "mtld": 153.86230144485327,
      "readability_fk_grade": 7.938982035928145,
      "coherence_mean": 0.1891505253698997,
      "prompt_relevance": 0.33250177158053296,
      "connective_density": 0.14705882352941177,
      "word_count": 1719,
      "repetition_rate": 0.026806526806526808
    },
    "human_review": {
      "flagged": true,
      "reasons": [
        "judge_disagreement",
        "block4_paradox_case"
      ],
      "sheet_path": "results/human_eval/run_54c40a4d1992.json"
    }
  }
}